Donaldson (DCI) 10-K 27 Sep 24 2024 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Jul. 31, 2024	Sep. 13, 2024	Jan. 31, 2024
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Current Fiscal Year End Date	--07-31
Document Period End Date	Jul. 31, 2024
Document Transition Report	false
Entity File Number	1-7891
Entity Registrant Name	DONALDSON COMPANY, INC.
Entity Incorporation, State	DE
Entity Tax Identification Number	41-0222640
Entity Address, Street Address	1400 West 94th Street
Entity Address, City	Minneapolis
Entity Address, State	MN
Entity Address, Postal Zip Code	55431
City Area Code	952
Local Phone Number	887-3131
Title of each class	Common Stock, $5.00 par value
Trading Symbol(s)	DCI
Name of each exchange on which registered	NYSE
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Emerging Growth Company	false
Entity Small Business	false
ICFR Auditor Attestation Flag	true
Document Financial Statement Error	false
Entity Shell Company	false
Entity Public Float			$ 7,729,445,706
Entity Common Stock, Shares Outstanding		119,732,101
Documents Incorporated by Reference	Portions of the registrant’s Proxy Statement for its 2024 annual meeting of stockholders (the “2024 Proxy Statement”) are incorporated by reference in Part III, as specifically set forth in Part III.
Entity Central Index Key	0000029644
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Jul. 31, 2024
Auditor Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	Minneapolis, Minnesota
Auditor Firm ID	238

CONSOLIDATED STATEMENTS OF EARN

CONSOLIDATED STATEMENTS OF EARNINGS - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Statement [Abstract]
Net sales	$ 3,586.3	$ 3,430.8	$ 3,306.6
Cost of sales	2,311.9	2,270.2	2,239.2
Gross profit	1,274.4	1,160.6	1,067.4
Selling, general and administrative	636.7	602.3	554.8
Research and development	93.6	78.1	69.1
Operating expenses	730.3	680.4	623.9
Operating income	544.1	480.2	443.5
Interest expense	21.4	19.2	14.9
Other income, net	(12.6)	(7.7)	(9.8)
Earnings before income taxes	535.3	468.7	438.4
Income taxes	121.3	109.9	105.6
Net earnings	$ 414	$ 358.8	$ 332.8
Weighted average shares – basic (in shares)	120.7	121.8	123.7
Weighted average shares – diluted (in shares)	122.6	123.6	125.2
Net earnings per share – basic (in usd per share)	$ 3.43	$ 2.95	$ 2.69
Net earnings per share – diluted (in usd per share)	$ 3.38	$ 2.90	$ 2.66

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Net earnings	$ 414	$ 358.8	$ 332.8
Other comprehensive income:
Foreign currency translation (loss) income	(24.2)	34	(99.6)
Pension liability adjustment, net of deferred taxes of $0.8, $(0.3) and $(2.1), respectively	(1.9)	0.3	7.2
Derivatives:
(Loss) gain on hedging derivatives, net of deferred taxes of $0.2, $0.5 and $(2.0), respectively	(0.6)	(1.4)	7.2
Reclassification of hedging derivatives to net earnings, net of taxes of $0.0, $(0.1) and $0.5, respectively	0.3	0.2	(2.2)
Total derivatives	(0.3)	(1.2)	5
Net other comprehensive (loss) income	(26.4)	33.1	(87.4)
Comprehensive income	$ 387.6	$ 391.9	$ 245.4

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Statement of Comprehensive Income [Abstract]
Pension liability adjustment, net of deferred taxes	$ 0.8	$ (0.3)	$ (2.1)
(Loss) gain on hedging derivatives, net of deferred taxes	0.2	0.5	(2)
Reclassification of hedging derivatives to net earnings, net of taxes	$ 0	$ (0.1)	$ 0.5

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Current assets:
Cash and cash equivalents	$ 232.7	$ 187.1
Accounts receivable, less allowances of $6.3 and $8.3, respectively	629.7	599.7
Inventories, net	476.7	418.1
Prepaid expenses and other current assets	99	81.1
Total current assets	1,438.1	1,286
Property, plant and equipment, net	645.5	652.9
Goodwill	478.4	481.1
Intangible assets, net	171.9	188.1
Other long-term assets	180.4	162.4
Total assets	2,914.3	2,770.5
Current liabilities:
Short-term borrowings	28.3	34.1
Current maturities of long-term debt	25	125
Accounts payable	379.4	304.9
Accrued employee compensation and related taxes	140.9	119.4
Deferred revenue	19.7	25.3
Income taxes payable	42.6	32.3
Dividend payable	32.5	30.4
Other current liabilities	114.1	85
Total current liabilities	782.5	756.4
Long-term debt	483.4	496.6
Non-current income taxes payable	39.8	56.5
Deferred income taxes	16.1	32.3
Other long-term liabilities	103.4	108
Total liabilities	1,425.2	1,449.8
Commitments and contingencies (Note 18)
Stockholders’ equity:
Preferred stock, $1.00 par value, 1,000,000 shares authorized, none issued	0	0
Common stock, $5.00 par value, 240,000,000 shares authorized, 151,643,194 shares issued	758.2	758.2
Additional paid-in capital	26.8	24.8
Retained earnings	2,377.5	2,087.8
Accumulated other comprehensive loss	(198.9)	(172.5)
Treasury stock, 31,533,192 and 30,528,696 shares, respectively, at cost	(1,474.5)	(1,377.6)
Total stockholders’ equity	1,489.1	1,320.7
Total liabilities and stockholders’ equity	$ 2,914.3	$ 2,770.5

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Statement of Financial Position [Abstract]
Accounts receivable, allowance	$ 6.3	$ 8.3
Preferred stock, par value (in usd per share)	$ 1	$ 1
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares issued (in shares)	0	0
Common stock, par value (in usd per share)	$ 5	$ 5
Common stock, shares authorized (in shares)	240,000,000	240,000,000
Common stock, shares issued (in shares)	151,643,194	151,643,194
Treasury stock, shares (in shares)	31,533,192	30,528,696

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Operating Activities
Net earnings	$ 414	$ 358.8	$ 332.8
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	98.4	92.3	93.8
Equity in earnings of affiliates, net of distributions	(4.7)	(1)	0.3
Deferred income taxes	(24.3)	(15.3)	(1.4)
Stock-based compensation expense	22	20.4	20.4
Other, net	3.7	7.3	10.6
Changes in operating assets and liabilities, excluding effect of acquired businesses:
Accounts receivable, net	(39.4)	30.1	(100.8)
Inventories, net	(65.6)	99.8	(147.8)
Prepaid expenses and other current assets	(28.3)	16.8	(10.5)
Accounts payable	80.3	(39)	51.1
Income taxes payable	4.4	(11.5)	4.9
Deferred revenue	(5.3)	2.1	8.3
Accrued employee compensation and related taxes and other current liabilities	37.3	(16.3)	(8.9)
Net cash provided by operating activities	492.5	544.5	252.8
Investing Activities
Purchases of property, plant and equipment	(85.6)	(118.5)	(85.5)
Proceeds from sale of property, plant and equipment	0.7	0.4	0.4
Acquisitions, net of cash acquired	(2)	(209.2)	(68.9)
Net cash used in investing activities	(86.9)	(327.3)	(154)
Financing Activities
Proceeds from long-term debt	119.7	189.2	289.3
Repayments of long-term debt	(228.8)	(219.6)	(90)
Change in short-term borrowings	(5.7)	30.4	(43.9)
Purchase of treasury stock	(162.7)	(141.8)	(170.6)
Payment of contingent consideration	(1.7)	0	0
Dividends paid	(122.8)	(114.4)	(110.1)
Tax withholding for stock compensation transactions	(8)	(4.3)	(1.8)
Exercise of stock options	54.1	38.3	12.9
Net cash used in financing activities	(355.9)	(222.2)	(114.2)
Effect of exchange rate changes on cash	(4.1)	(1.2)	(14.1)
Increase (decrease) in cash and cash equivalents	45.6	(6.2)	(29.5)
Cash and cash equivalents, beginning of year	187.1	193.3	222.8
Cash and cash equivalents, end of year	232.7	187.1	193.3
Supplemental Cash Flow Information
Income taxes paid	147.8	140.9	102.4
Interest paid	23.4	20.9	12.2
Supplemental Disclosure of Non-Cash Operating and Investing Transactions
Accrued property, plant and equipment additions	14.2	18.5	16.3
Leased assets obtained in exchange for new operating lease liabilities	$ 22.7	$ 32.3	$ 17

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Loss	Treasury Stock
Beginning balance at Jul. 31, 2021	$ 1,137.1	$ 758.2	$ 3.2	$ 1,623.8	$ (118.2)	$ (1,129.9)
Comprehensive income
Net earnings	332.8			332.8
Foreign currency translation	(99.6)				(99.6)
Pension liability adjustment, net of deferred taxes	7.2				7.2
Gains (losses) on hedging derivatives, net of deferred taxes	7.2				7.2
Reclassification of gains (losses) on hedging derivatives to net earnings	(2.2)				(2.2)
Comprehensive income	245.4
Treasury stock acquired	(170.6)					(170.6)
Stock options exercised	13.3		(2.5)			15.8
Stock compensation expense	20.4		20.5			(0.1)
Deferred stock and other activity	(1.7)		(4.2)	(0.2)		2.7
Dividends declared	(110.7)			(110.7)
Ending balance at Jul. 31, 2022	1,133.2	758.2	17	1,845.7	(205.6)	(1,282.1)
Comprehensive income
Net earnings	358.8			358.8
Foreign currency translation	34				34
Pension liability adjustment, net of deferred taxes	0.3				0.3
Gains (losses) on hedging derivatives, net of deferred taxes	(1.4)				(1.4)
Reclassification of gains (losses) on hedging derivatives to net earnings	0.2				0.2
Comprehensive income	391.9
Treasury stock acquired	(141.8)					(141.8)
Stock options exercised	36.9		(5.2)			42.1
Stock compensation expense	20.4		20.2			0.2
Deferred stock and other activity	(3.5)		(7.2)	(0.3)		4
Dividends declared	(116.4)			(116.4)
Ending balance at Jul. 31, 2023	1,320.7	758.2	24.8	2,087.8	(172.5)	(1,377.6)
Comprehensive income
Net earnings	414			414
Foreign currency translation	(24.2)				(24.2)
Pension liability adjustment, net of deferred taxes	(1.9)				(1.9)
Gains (losses) on hedging derivatives, net of deferred taxes	(0.6)				(0.6)
Reclassification of gains (losses) on hedging derivatives to net earnings	0.3				0.3
Comprehensive income	387.6
Treasury stock acquired	(163.3)					(163.3)
Stock options exercised	53		(6.4)			59.4
Stock compensation expense	22		21.8			0.2
Deferred stock and other activity	(6)		(13.4)	0.6		6.8
Dividends declared	(124.9)			(124.9)
Ending balance at Jul. 31, 2024	$ 1,489.1	$ 758.2	$ 26.8	$ 2,377.5	$ (198.9)	$ (1,474.5)

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Parenthetical) - $ / shares	3 Months Ended	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Statement of Stockholders' Equity [Abstract]
Dividends declared (in usd per share)	$ 0.270	$ 1.04	$ 0.96	$ 0.90

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1. Summary of Significant Accounting Policies Description of Business Donaldson Company, Inc. (the Company) is a global leader in technology-led filtration products and solutions. The Company’s core strengths include leading filtration technology, diverse business and a global presence. Products are manufactured and sold around the world to original equipment manufacturers (OEMs), distributors, dealers and directly to end users. Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and all its majority-owned subsidiaries. All intercompany accounts and transactions have been elimin ated. The Company’s joint ventures are not majority-owned and are accounted for under the equity meth od. The Company is party to joint ventures with Advanced Filtration Systems Inc. (AFSI) and PT Panata Jaya Mandiri (PTPJM), both of which are considered related parties. The investment and earnings from joint ventures are not material. Certain reclassifications to previously reported financial information on the Consolidated Balance Sheet, Consolidated Statements of Cash Flows and Consolidated Statements of Changes in Stockholders’ Equity have been made to conform to the current period presentation. Use of Estimates The preparation of the Company’s financial statements in conformity with generally accepted accounting principles (GAAP) in the United States (U.S.) requires management to make estimates and assumptions that affect the amount of assets and liabilities and the disclosures regarding contingent assets and liabilities at period end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. Operating Environment Foreign Currency Translation For most foreign operations, local currencies are considered the functional currency. Assets and liabilities of non-U.S. dollar functional currency entities are translated to U.S. dollars at fiscal year end exchange rates and the resulting gains and losses arising from the translation of net assets located outside the U.S. are recorded as a cumulative translation adjustment, a component of accumulated other comprehensive loss on the Consolidated Balance Sheets. Elements of the Consolidated Statements of Earnings are translated at average exchange rates in effect during the fiscal year. Foreign currency transaction losses are included in other income, net in the Consolidated Statements of Earnings and were $1.7 million, $6.4 million and $6.3 million in the years ended July 31, 2024, 2023 and 2022, respectively. Cash Equivalents The Company considers all highly liquid temporary investments with an original maturity of three months or less to be cash equivalents. Cash equivalents are carried at cost which approximates market value. Revenue Recognition Revenue is measured as the amount of consideration the Company expects to receive in exchange for the fulfillment of performance obligations. The transaction price of a contract could be reduced by variable consideration including volume purchase rebates and discounts, product refunds and returns. At the time of sale to a customer, the Company records an estimate of variable consideration as a reduction from gross sales. The Company primarily relies on historical experience and anticipated future performance to estimate the variable consideration. Revenue is recognized to the extent it is probable a significant reversal of revenue will not occur when the contingency is resolved. The Company accounts for amounts billed to customers for reimbursement of shipping and handling costs by recording these amounts as revenue and accruing costs when the related revenue is recognized. For most customer contracts, the Company recognizes revenue at a point in time when control of the goods or services is transferred to the customer. For product sales, control is typically deemed to have transferred in accordance with the shipping terms, either at the time of shipment from the plants or distribution centers or the time of delivery to the customers. Revenue is recognized for services upon completion o f those services. Payment terms vary by customer and the geographic location of the customer. The Company’s contracts with customers do not include significant financing components or non-cash consideration. The Company has some contracts with customers where the performance obligations are satisfied over time. Certain customer contracts provide the Company with an enforceable right to payment of the transaction price for performance completed to date and the Company uses either an input or an output method of production to measure the progress towards the completion of the performance obligation in these arrangements, depending on the nature of the contract. The timing of revenue recognized from these products is slightly accelerated compared to revenue recognized at the time of shipment or delivery. The Company generally does not incur significant incremental costs related to obtaining or fulfilling a contract prior to the start of a project. The Company may incur certain fulfillment costs such as initial design or mobilization costs which are capitalized if they relate directly to the contract, if they are expected to generate resources that will be used to satisfy the Company’s performance obligation under the contract and if they are expected to be recovered through revenues generated under the contract. Such costs, which are amortized over the life of the respective project, were not material for any period presented. The Company does not pay upfront sales commissions on contracts when the related contract period is greater than one year and thus has not capitalized any amounts as of July 31, 2024 and 2023 , see Note 3. Shipping and Handling Shipping and handling costs on products sold of $91.5 million , $91.2 million and $96.4 million are classified as a component of operating expenses in the Consolidated Statements of Earnings for the years ended July 31, 2024, 2023 and 2022, respectively. Accounts Receivable, Net and Allowance for Doubtful Accounts Accounts receivable, net are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of credit losses in its existing accounts receivable. The Company determines the allowance based on utilization of a combination of aging schedules with reserve rates applied to both current and aged receivables using historical write-off experience, regional economic data and evaluation of specific customer accounts for risk of loss and changes in current or projected conditions to calculate the allowances related to accounts receivable, net. The Company reviews its allowance for doubtful accounts monthly. Account balances are reviewed on a pooled basis by reporting unit and geographic region and are reserved when the Company determines it is probable the receivable will not be recovered. The Company reduces the receivable and corresponding allowance when it confirms an account is uncollectible. Factoring Arrangements The Company has agreements with financial institutions to sell certain trade receivables from customers without recourse. The Company accounts for trade receivable transfers as sales and de-recognizes the sold receivables from the Consolidated Balance Sheets. During fiscal 2024, the Company sold $29.9 million re ceivables under factoring agreements. Costs incurred on these sales during the year ended July 31, 2024 were $1.7 million and are included in the cost of sales within the Consolidated Statements of Earnings. Cash received from selling receivables of $28.2 million is presented as a change in accounts receivable within the operating section of the Consolidated Statements of Cash Flow. Inventories Inventories are stated at the lower of cost and net realizable value. U.S. inventories are valued using the last-in, first-out (LIFO) method while the non-U.S. inventories are valued using the first-in, first-out (FIFO) method. Inventories valued at LIFO were approximately 35.3% and 29.7% of total inventories as of July 31, 2024 and 2023, respectively. For inventories valued under the LIFO method, the FIFO cost exceeded the LIFO carrying values by $51.3 million and $56.1 million as of July 31, 2024 and 2023, respectively. Results of operations for all periods presented were not materially affected by the liquidation of LIFO inventory. Property, Plant and Equipment Property, plant and equipment are stated at cost. Additions, improvements or major renewals are capitalized while expenditures that do not enhance or extend the asset’s useful life are expensed as incurred. Depreciation is computed using the straight-line method. Depreciation expense was $82.8 million, $80.9 million and $85.1 million in the years ended July 31, 2024, 2023 and 2022, respectively. The estimated useful lives of property, plant and equipment are 10 to 40 years for buildings, including building improvements and three Internal-Use Software and Cloud Computing Arrangements The Company capitalizes direct costs of materials and services used in the development and purchase of internal-use software. Amounts capitalized are amortized on a straight-line basis over a period of five The Company capitalizes certain costs incurred during the application development stage of implementation of internal-use software in cloud computing arrangements. Amounts capitalized are amortized on a straight-line basis over a period of five Goodwill and Intangible Assets Goodwill represents the excess of the purchase price over the fair value of net assets acquired in business combinations under the purchase method of accounting. Goodwill is assessed for impairment annually or if an event occurs or circumstances change that would indicate the carrying amount may be impaired. The Company performed its annual impairment assessment during the third quarter of fiscal 2024. The goodwill impairment assessment is conducted at a reporting unit level, which is one level below the operating segment level and utilizes either a qualitative or quantitative assessment. The Company determined the fair value for all its reporting units was substantially in excess of their respective carrying values and there were no indicators of impairment for any of the reporting units evaluated. An impairment loss would be recognized when the carrying amount of a reporting unit’s net assets exceeds the estimated fair value of the reporting unit, see Note 6. Intangible assets, comprised of customer relationships, trademarks, technology and patents and non-compete agreements, are amortized on a straight-line basis over their estimated useful lives of 2 to 22 years. Business Combinations The Company allocates the purchase price of acquired businesses to the estimated fair values of the assets acquired and liabilities assumed, as well as any contingent consideration, where applicable, as of the date of acquisition. The fair values of the long-lived assets acquired, primarily intangible assets, are determined using calculations which can be complex and require significant judgment. Estimates include many factors such as the nature of the acquired company’s business, its historical financial position and results, technology obsolescence, customer retention rates, discount rates, royalty rates and expected future performance. Independent valuation specialists are used to assist in determining certain fair value calculations. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Any adjustments required after the measurement period are recorded in the Consolidated Statements of Earnings. Recoverability of Long-Lived Assets The Company reviews its long-lived assets, including identifiable intangibles, for impairment when events or changes in circumstances indicate the carrying amount of an asset may not be recoverable. If impairment indicators are present and the estimated future undiscounted cash flows are less than the carrying value of the assets, the carrying value is reduced to the fair market value. There were no indicators of impairment or impairment charges recorded for the years ended July 31, 2024, 2023 and 2022. Income Taxes The provision for income taxes is computed based on the pretax income reported for financial statement purposes. Deferred tax assets and liabilities are recognized for the expected future tax consequences attributed to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are anticipated to reverse. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not a tax benefit will not be realized. The Company maintains a reserve for uncertain tax benefits. Benefits of tax return positions are recognized in the financial statements when the position is more likely than not to be sustained by the taxing authorities based solely on the technical merits of the position. If the recognition threshold is met, the tax benefit is measured and recognized as the largest amount of tax benefit that is greater than 50% likely to be realized, in the Company’s judgment, see Note 8. Leases The Company determines whether an arrangement that provides control over the use of an asset to the Company is a lease. The Company recognizes a lease liability and corresponding right-of-use asset on the Consolidated Balance Sheets based on the present value of future lease payments and recognizes lease expense on a straight-line basis over the lease term. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term (or at fair values in the case of those leases assumed in an acquisition). Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term. Variable lease expense is immaterial and primarily includes leases with payments indexed to inflation when the index changes after lease commencement. The Company has elected to separate payments fo r lease components from non-lease components for all asset classes. Lease agreements may include extension, termination or purchase options, all of which are considered in calculating the lease liability and right-of-use asset when it is reasonably certain the Company will exercise an option. The Company’s incremental borrowing rate on the commencement date is used to calculate the present value of future payments for most leases since the rate implicit in the lease is generally not readily determinable. These rates are assessed on a quarterly basis for measurement of new lease obligations, see Note 9. Stock-Based Compensation Stock-based compensation expense is recognized using the fair value method for all awards, see Note 13. Treasury Stock Repurchased common stock is stated at cost, determined on an average cost basis and is presented as a reduction of stockholders’ equity on the Consolidated Balance Sheets. Research and Development Expenses Research and development expenses include scientific research costs such as salaries, facility costs, testing, technical information technology and administrative expenditures. Research and development expenses are for the application of scientific advances to the development of new and improved products and their uses. Substantially all research and development is performed in-house. Expenses are charged against earnings in the year incurred. Foreign Currency Forward Contracts - Cash Flow Hedges and Derivatives Not Designated as Hedging Instruments The Company buys materials from foreign suppliers. Those transactions can be denominated in those suppliers’ local currency. The Company also sells to customers in foreign countries. Those transactions can be denominated in those customers’ local currency. Both of these transaction types can create volatility in the Company’s financial statements. The Company uses foreign currency forward contracts to manage those exposures and fluctuations. These contracts generally mature in 12 months or less, which is consistent with the forecasts of the rel ated purchases and sales. Certain contracts are designated as cash flow hedges, whereas the remaining contracts, most of which are related to certain intercompany transactions which offset balance sheet exposure, are not designated as hedging instruments, see Notes 12, 15 and 16. Net Investment Hedges The Company uses fixed-to-fixed cross-currency swap agreements to hedge its exposure to adverse foreign currency exchange rate movements for its operations in Europe. The Company has elected the spot method for designating these contracts as net investment hedges. The maturity dates range from 2027 to 2029, see Notes 12, 15 and 16. Interest Rate Swaps - Cash Flow Hedges The Company uses swap agreements to hedge exposure related to interest expense and to manage its exposure to interest rate movements. The Company enters into interest rate s wap agreements designated as cash flow hedges to hedge future fixed-rate debt issuances, which effectively fix a portion of interest payments. Product Warranties The Company provides for estimated warranty expense at the time of sale and accrues for specific items at the time their existence is known and the amounts are determinable. The Company estimates warranty expense on certain products at the time of sale using quantitative measures based on historical warranty claim experience and evaluation of specific customer warranty issues, see Note 18. New Significant Accounting Standards Recently Adopted There were no new significant accounting standards adopted in fiscal 2024 or 2023 that had a material impact on the Company’s financial statements. New Significant Accounting Standards Not Yet Adopted The Company considers the applicability and impact of the FASB’s ASUs issued but not yet adopted. In December 2023, FASB issued ASU No. 2023-09, Income Taxes (Topic 820), “Improvements to Income Tax Disclosures,” which enhances the transparency and decision usefulness of income tax disclosures. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect adoption of this standard will have a material impact on the related disclosures within its financial statements. In November 2023, FASB issued ASU No. 2023-07, Segment Reporting (Topic 280), “Improvements to Reportable Segment Disclosures,” which improves the segment disclosures to include reportable segment’s expenses. The guidance is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. This ASU is applicable to annual reporting for the Company’s fiscal 2025 and interim reporting for the first quarter of the Company’s fiscal 2026. The Company does not expect adoption of this standard will have a material impact on the related disclosures within its financial statements. In October 2023, FASB issued ASU No. 2023-06, "Disclosure Improvements: Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative," which modifies the disclosure or presentation requirements of various FASB topics in the Codification. The effective date for each amendment will be the date on which the SEC's removal of that related disclosure from Regulation S-K becomes effective, with early adoption prohibited. The Company is in the process of evaluating the impact of the ASU on its related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820), “ Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions,” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair values; it also requires additional disclosures, including the nature and remaining duration of such restrictions. The guidance is effective for fiscal years beginning after December 15, 2023, with early application permitted. This ASU is applicable to the Company’s fiscal year beginning in the first quarter of fiscal 2025. The Company does not expect adoption of this standard will have a material impact on its financial statements.

Acquisitions and Equity Method

Acquisitions and Equity Method Investments	12 Months Ended
	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Acquisitions and Equity Method Investments	Note 2. Acquisitions and Equity Method Investments Acquisitions There have been no material acquisitions in fiscal 2024. Univercells Technologies (UTEC) In the fourth quarter of fiscal 2023, the Company acquired UTEC, headquartered in Nivelles, Belgium, for cash consideration of €134.6 million, or $147.2 million, net of cash acquired. UTEC is a global producer of innovative biomanufacturing solutions for cell and gene therapy research, development and commercial manufacturing. UTEC is reported within the Company’s Life Sciences segment. The Company assigned the fair values to the net assets acquired resulting in $95.8 million for goodwill and $52.5 million for intangible assets, the amortization of which is not deductible for tax purposes. The valuation resulted in a deferred tax liability of $13.1 million and a deferred tax asset of $7.0 million. Net working capital was a net liability of $0.9 million, and there were $6.6 million of other non-current assets and $0.7 million of other non-current liabilities. Purchase accounting was finalized in the third quarter of fiscal 2024. Net sales of UTEC were immaterial to the Consolidated Statements of Earnings for the year ended July 31, 2023. Isolere Bio, Inc. (Isolere) In the third quarter of fiscal 2023, the Company acquired Isolere, headquartered in Durham, North Carolina, for cash consideration of $62.4 million, net of cash acquired. Isolere develops reagents and accompanying filtration processes used for the purification and streamlined manufacturing of biopharmaceuticals. Isolere is reported within the Company’s Life Sciences segment. The Company assigned the fair values to the net assets acquired resulting in $28.2 million for goodwill and $44.5 million for intangible assets, the amortization of which is not deductible for tax purposes, resulting in a deferred tax liability of $10.9 million. Net working capital was a net liability of $0.4 million, and there were $1.2 million of other non-current assets and $0.2 million other non-current liabilities. Purchase accounting was finalized in the first quarter of fiscal 2024. Net sales of Isolere were immaterial to the Consolidated Statements of Earnings for the year ended July 31, 2023. 2023 Purchase Price Summary The components of the UTEC and Isolere acquisitions, net of cash acquired, as of the acquisition date were as follows (in millions): 2023 Intangible assets: Technology $ 84.9 Trademarks and tradenames 8.2 Customer relationships 1.2 Non-competition agreements 2.7 Intangible assets acquired 97.0 Tangible assets, net 10.4 Assets acquired, net 107.4 Goodwill 124.0 Aggregate purchase price 231.4 Add deferred tax asset 7.0 Less deferred tax liability (24.0) Less cash acquired (4.8) Acquisitions, net of cash acquired $ 209.6 Purilogics, LLC (Purilogics) In the fourth quarter of fiscal 2022, the Company acquired Purilogics, headquartered in Greenville, South Carolina, for cash consideration of approximately $19.9 million, net of cash acquired. The transaction included a maximum payout of $29.0 million in contingent consideration related to developing manufacturing capabilities, creating future technologies and attaining certain business performance results. Purilogics is a biotechnology company that leverages a novel technology platform for the development of membrane chromatography products. Purilogics offers a broad portfolio of purification tools for a wide range of biologics. Purilogics’ proprietary formulations and processes create membranes that have significant competitive advantages, enabling faster and more cost-effective production of increasingly complex biologic drugs. Purilogics is reported within the Company’s Life Sciences segment. Purchase accounting was finalized in the second quarter of fiscal 2023. Net sales of Purilogics were immaterial to the Consolidated Statements of Earnings for the year ended July 31, 2022. Solaris Biotechnology S.r.l. (Solaris) In the second quarter of fiscal 2022, the Company acquired Solaris, headquartered in Porto Mantovano, Italy, with U.S. operations based in Berkeley, California, for cash consideration of approximately €41 million, or $45.7 million, net of cash acquired. Solaris designs and manufactures bioprocessing equipment, including bioreactors, fermenters and tangential flow filtration systems for use in food and beverage, biotechnology and other life sciences markets. Solaris is reported within the Company’s Life Sciences segment. Purchase accounting was finalized in the fourth quarter of fiscal 2022. Net sales of Solaris were immaterial to the Consolidated Statements of Earnings for the year ended July 31, 2022. Pearson Arnold Industrial Services (PAIS) In the second quarter of fiscal 2022, the Company acquired PAIS, headquartered in the U.S., for cash consideration of approximately $3.3 million, net of cash acquired. PAIS provides equipment, parts and services for dust, mist and fume collection systems, industrial fans and compressed air systems. PAIS is reported within the Company’s Industrial Filtration Solutions (IFS) business in the Industrial Solutions segment. Goodwill and intangible assets acquired are deductible for tax purposes. Purchase accounting was finalized in the fourth quarter of fiscal 2022. Net sales of PAIS were immaterial to the Consolidated Statements of Earnings for the year ended July 31, 2022. Equity Method Investments Subsequent to year end, on August 9, 2024, the Company acquired a 49% non-controlling stake in Medica S.p.A. (Medica), headquartered in Medolla, Italy, for cash consideration of approximately €62 million, or $68 million. Medica is a leader in hollow fiber membrane filtration technology for medical applications and water purification. The Company has the option to acquire the remaining 51% stake in four years. Pro forma Financial Information Pro forma financial information for these acquisitions has not been presented because the acquisitions were not material to the Company’s Consolidated Statements of Earnings. See Note 6 for goodwill and intangible assets acquired.

Revenue

Revenue	12 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	Note 3. Revenue The Company recognizes revenue on a wide range of filtration solutions sold to customers in many industries around the globe. Most of the Company’s performance obligations within customer sales contracts are for manufactured filtration systems and replacement parts. The Company also performs limited services and installation. Customer contracts may include multiple performance obligations and the transaction price is allocated to each distinct performance obligation based on its relative standalone selling price. Revenue Disaggregation Net sales, generally disaggregated by location where the customer’s order was placed, were as follows (in millions): Year Ended July 31, 2024 2023 2022 U.S. and Canada $ 1,583.1 $ 1,464.7 $ 1,336.8 Europe, Middle East and Africa (EMEA) 1,012.9 1,007.8 963.6 Asia Pacific (APAC) 601.5 608.8 669.0 Latin America (LATAM) 388.8 349.5 337.2 Total net sales $ 3,586.3 $ 3,430.8 $ 3,306.6 See Note 19 for net sales disaggregated by segment and business unit. Contract Assets and Liabilities The satisfaction of performance obligations and the resulting recognition of revenue typically correspond with billing of the customer. In limited circumstances, the customer may be billed at a time later than when revenue is recognized, resulting in contract assets, which are reported in other current assets on the Consolidated Balance Sheets. Contract assets were $15.9 million and $13.3 million as of July 31, 2024 and 2023, respectively. In other limited circumstances, the customer may make a payment at a time earlier than when revenue is recognized and prior to the satisfaction of performance obligations, resulting in contract liabilities, which are reported in deferred revenue on the Consolidated Balance Sheets. Contract liabilities were $19.7 million and $25.3 million as of July 31, 2024 and 2023, respectively. The Company will recognize revenue in future periods related to remaining performance obligations for certain open contracts. Generally, these contracts have terms of one year or less. The amount of revenue related to unsatisfied performance obligations in which the original duration of the contract is greater than one year is not significant. None of the Company’s contracts contained a significant financing component.

Inventories, Net

Inventories, Net	12 Months Ended
	Jul. 31, 2024
Inventory Disclosure [Abstract]
Inventories, Net	Note 4. Inventories, Net The components of inventories, net were as follows (in millions): July 31, 2024 2023 Raw materials $ 177.4 $ 155.1 Work in process 61.2 50.9 Finished products 238.1 212.1 Total inventories, net $ 476.7 $ 418.1

Property, Plant and Equipment,

Property, Plant and Equipment, Net	12 Months Ended
	Jul. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	Note 5. Property, Plant and Equipment, Net The components of property, plant and equipment, net were as follows (in millions): July 31, 2024 2023 Land $ 29.5 $ 29.3 Buildings 451.9 430.8 Machinery and equipment 1,052.1 989.0 Computer software 134.7 142.0 Construction in progress 68.4 107.7 Less accumulated depreciation (1,091.1) (1,045.9) Total property, plant and equipment, net $ 645.5 $ 652.9

Goodwill and Intangible Assets

Goodwill and Intangible Assets	12 Months Ended
	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets	Note 6. Goodwill and Intangible Assets Goodwill The Company allocates goodwill to reporting units within its Mobile Solutions, Industrial Solutions and Life Sciences segments. There were no dispositions or impairment charges recorded during the years ended July 31, 2024, 2023 and 2022. Goodwill is assessed for impairment annually during the third quarter of the fiscal year, or more frequently if events or changes in circumstances indicate the asset may be impaired. The Company performed its annual impairment assessment during the third quarter of fiscal 2024 and did not record any impairment as a result of this assessment. Goodwill by reportable segment was as follows (in millions): Mobile Industrial Life Sciences Segment Total Balance as of July 31, 2022 $ 25.3 $ 282.1 $ 38.4 $ 345.8 Goodwill acquired — — 125.1 125.1 Foreign exchange translation 0.2 7.0 3.0 10.2 Balance as of July 31, 2023 $ 25.5 $ 289.1 $ 166.5 $ 481.1 Goodwill acquired — 1.9 — 1.9 Purchase price adjustments — — (1.1) (1.1) Foreign exchange translation (0.1) (1.1) (2.3) (3.5) Balance as of July 31, 2024 $ 25.4 $ 289.9 $ 163.1 $ 478.4 Intangible Assets Intangible assets recognized from the UTEC acquisition in fiscal 2023 were $52.5 million, of which $43.2 million was technology with an 18 year useful life, $6.7 million was trademarks with a 10 year useful life, $1.4 million was non-competition agreements with a two year useful life and $1.2 million was customer relationships with a 10 year useful life. Purchase accounting was finalized in the third quarter of fiscal 2024. Intangible assets recognized from the Isolere acquisition in fiscal 2023 were $44.5 million, of which $41.7 million was technology with a 20 year useful life, trademarks and tradenames were $1.5 million with a 10 year useful life and non-competition agreements were $1.3 million with a three year useful life. Purchase accounting was finalized in the first quarter of fiscal 2024. There was a foreign currency translation loss of $1.4 million in fiscal 2024 and translation gain of $3.2 million in fiscal 2023. Intangible asset classes were as follows (in millions): Year Ended July 31, 2024 Weighted Amortizable Life (in Years) Gross Carrying Amount Accumulated Amortization Net Customer relationships 9.4 $ 77.4 $ (39.9) $ 37.5 Trademarks 8.1 14.2 (3.8) 10.4 Technology and patents 16.7 142.4 (20.4) 122.0 Non-compete agreements 2.7 3.9 (1.9) 2.0 Total intangible assets $ 237.9 $ (66.0) $ 171.9 Year Ended July 31, 2023 Weighted Amortizable Life (in Years) Gross Carrying Amount Accumulated Amortization Net Customer relationships 10.8 $ 107.8 $ (65.6) $ 42.2 Trademarks 9.0 15.9 (3.9) 12.0 Technology and patents 17.6 149.7 (19.2) 130.5 Non-compete agreements 3.1 4.0 (0.6) 3.4 Total intangible assets $ 277.4 $ (89.3) $ 188.1 Intangible asset amortization expense w as $15.7 million, $11.4 million and $9.2 million for the fiscal 2024, 2023 and 2022, respectively and is included in operating expenses in the Consolidated Statements of Earnings. Amortization expense relating to existing intangible assets as of July 31, 2024 was as follows (in millions): 2025 $ 15.3 2026 14.1 2027 13.7 2028 13.2 2029 12.1 Thereafter 103.5 Total amortization expense $ 171.9

Short-Term Borrowings and Long-

Short-Term Borrowings and Long-Term Debt	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Short-Term Borrowings and Long-Term Debt	Note 7. Short-Term Borrowings and Long-Term Debt Short-Term Borrowings Short-term borrowings were as follows (in millions): European Commercial Paper Program U.S. Credit Facilities European Operations Credit Facilities Rest of the World Credit Facilities Total Year Ended July 31, 2024 2023 2024 2023 2024 2023 2024 2023 2024 2023 Available credit facilities $ 108.3 $ 110.3 $ 100.0 $ 100.0 $ 48.4 $ 45.0 $ 46.7 $ 50.8 $ 303.4 $ 306.1 Reductions to borrowing capacity: Outstanding borrowings 22.8 24.3 0.2 9.8 — — 5.3 — 28.3 34.1 Other non-borrowing reductions — — — — 38.9 28.8 25.7 18.8 64.6 47.6 Total reductions 22.8 24.3 0.2 9.8 38.9 28.8 31.0 18.8 92.9 81.7 Remaining borrowing capacity $ 85.5 $ 86.0 $ 99.8 $ 90.2 $ 9.5 $ 16.2 $ 15.7 $ 32.0 $ 210.5 $ 224.4 Weighted average interest rate as of July 31, 2024 and 2023 4.34 % 4.09 % 6.44 % 6.17 % N/A N/A 0.56 % N/A 3.62 % 4.69 % Other non-borrowing reductions include financial instruments such as bank guarantees and foreign currency exchange instruments. Commitment fees for the years ended July 31, 2024 and 2023 were not material. Long-Term Debt Long-term debt was as follows: Interest Rate Outstanding Balance Financial Instrument Fixed or Variable Amount Maturity Date July 31, 2024 July 31, 2023 July 31, 2024 July 31, 2023 Unsecured senior notes Fixed $125.0 million March 27, 2024 3.72 % 3.72 % $ — $ 125.0 Unsecured senior notes Fixed $125.0 million June 17, 2030 3.18 % 3.18 % 125.0 125.0 Unsecured senior notes Fixed $100.0 million August 5, 2031 2.50 % 2.50 % 100.0 100.0 Unsecured revolving credit facility Variable $500.0 million May 21, 2026 6.44 % 5.09 % 110.0 96.2 Unsecured term loan Variable €80.0 million March 26, 2029 4.69 % 4.41 % 86.6 88.2 Unsecured senior notes Fixed $50.0 million November 5, 2028 2.12 % 2.12 % 50.0 50.0 Unsecured senior notes Fixed $25.0 million April 16, 2025 2.93 % 2.93 % 25.0 25.0 Unsecured term loan Variable ¥1.0 billion July 31, 2028 0.76 % 0.57 % 6.7 7.0 Unsecured term loan Variable ¥1.0 billion July 15, 2026 0.68 % 0.49 % 6.7 7.0 Debt issuance costs, net (1.6) (1.8) Subtotal 508.4 621.6 Less current maturities (25.0) (125.0) Total long-term debt $ 483.4 $ 496.6 The Company’s $500.0 million revolving credit facility is with a group of lenders and allows for borrowings in multiple currencies. The interest rate is calculated using the appropriate benchmark rate plus the applicable rate. The borrowing availability can be reduced or the agreement terminated early at the option of the Company. The Company can request to increase the revolving credit facility by up to $250.0 million, subject to terms of the credit facility agreement, including written notification and lender acceptance, through an accordion feature. Borrowings are automatically rolled over until the credit facility maturity date, unless the agreement is terminated early or the Company is found to be in default. The total facility includes a commitment fee of 0.08% to 0.25%, depending on the Company’s leverage ratio. Certain debt agreements contain financial c ovenants related to interest coverage and leverage ratios, as well as other non-financial covenants. As of July 31, 2024, the Company was in compliance with all such covenants. The Company has long-term borrowing capacity of $382.5 million available for further borrowing under the existing credit facility as of July 31, 2024. The remaining borrowing capacity has been reduced for standby letters of credit as discussed in Note 17. Future maturities of the Company’s long-term debt as of July 31, 2024 were as follows (in millions): 2025 $ 25.0 2026 116.7 2027 — 2028 6.7 2029 136.6 Thereafter 225.0 Total future maturities payments 510.0 Less debt issuance costs, net (1.6) Total future maturities payments, net of debt issuance costs $ 508.4

Income Taxes

Income Taxes	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Income Taxes	Note 8. Income Taxes The components of earnings before income taxes were as follows (in millions): Year Ended July 31, 2024 2023 2022 U.S. $ 233.4 $ 178.0 $ 132.8 Foreign 301.9 290.7 305.6 Total $ 535.3 $ 468.7 $ 438.4 The components of the provision for income taxes were as follows (in millions): Year Ended July 31, 2024 2023 2022 Current Federal $ 47.2 $ 38.1 $ 17.4 State 8.8 7.3 4.9 Foreign 89.6 79.8 84.7 Total current 145.6 125.2 107.0 Deferred Federal (16.1) (13.3) 2.8 State (1.7) (1.8) (0.3) Foreign (6.5) (0.2) (3.9) Total deferred (24.3) (15.3) (1.4) Total provision for income taxes $ 121.3 $ 109.9 $ 105.6 The reconciliation of the U.S. statutory federal income tax rate with the effective income tax rate was as follows: Year Ended July 31, 2024 2023 2022 U.S. statutory federal income tax rate 21.0 % 21.0 % 21.0 % State income taxes 1.2 0.9 0.9 Foreign operations 2.7 3.8 3.6 Global Intangible Low Tax Income 0.2 0.2 0.3 Foreign Derived Intangible Income (1.3) (1.6) (0.6) Research and development credit (0.9) (0.7) (0.6) Change in unrecognized tax benefits 1.2 — (0.8) Tax benefits on stock-based compensation (1.2) (0.7) (0.5) Other (0.2) 0.5 0.8 Effective income tax rate 22.7 % 23.4 % 24.1 % The tax effects of temporary differences that give rise to deferred tax assets and liabilities were as follows (in millions): July 31, 2024 2023 Deferred tax assets Accrued expenses $ 14.3 $ 12.2 Compensation and retirement plans 26.6 24.7 Capitalization of R&D costs 32.9 17.6 Net operating loss (NOL) and tax credit carryforwards 17.6 15.1 Operating lease assets 15.6 15.0 Other 6.2 6.2 Gross deferred tax assets 113.2 90.8 Valuation allowance (9.1) (6.4) Deferred tax assets, net of valuation allowance 104.1 84.4 Deferred tax liabilities Depreciation and amortization (74.5) (79.5) Operating lease liabilities (14.9) (15.1) Other (3.8) (4.2) Deferred tax liabilities (93.2) (98.8) Net deferred tax asset (liability) $ 10.9 $ (14.4) The activity in the NOL and tax credit valuation allowances was as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ (6.4) $ (3.4) $ (4.6) Additions charged to costs and expenses (3.6) (3.0) (0.9) Deductions from reserves 0.9 — 2.1 Balance as of end of year $ (9.1) $ (6.4) $ (3.4) As of July 31, 2024, the Company had def erred tax assets related to U.S. federal foreign tax credits of $6.3 million, related to state research and development credits of $3.4 million and related to foreign operating loss carryovers of $6.4 million. The U.S. federal tax credits will expire after 10 years, the state portion after one As of July 31, 2024, the total undistributed earnings of the Company’s non-U.S. subsidiaries were $1.4 billion, of which $1.0 billion were not considered indefinitely reinvested. The Company is subject to foreign withholding taxes on a small portion of these earnings distributable in the future in the form of dividends. Thus, the Company provides for foreign withholding taxes payable upon future dividend distributions of the earnings not considered indefinitely reinvested annually. For the year ended July 31, 2024, the Company recognized a tax charge of $6.6 million related to these foreign withholding taxes. The remaining $380.8 million of earnings are considered indefinitely reinvested and it is not practicable to estimate, within any reasonable range, the additional taxes that may be payable on the potential distribution of the portion of the undistributed earnings considered indefinitely reinvested. The transition tax related to the U.S. Tax Cuts and Jobs Act of 2017 on undistributed earnings was accrued in fiscal 2018 and it is payable over an eight year period. The portion not due within 12 months classified in non-current income taxes payable on the Consolidated Balance Sheets as of July 31, 2024 was $22.1 million. The reconciliation of the beginning and ending amount of gross unrecognized tax benefits was as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ 15.0 $ 15.2 $ 18.7 Additions for tax positions of the current year 2.8 2.5 2.7 Additions for tax positions of prior years 6.2 — — Reductions for tax positions of prior years (0.1) 0.1 (1.1) Reductions due to lapse of applicable statute of limitations (3.1) (2.8) (5.1) Balance as of end of year $ 20.8 $ 15.0 $ 15.2 The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income taxes in the Consolidated Statements of Earnings. As of July 31, 2024 and 2023, accrued interest and penalties on a gross basis were $2.2 million and $1.7 million, respectively. During the year ended July 31, 2024, the Company recognized interest expense, net of tax benefit, of $0.8 million. If the Company were to prevail on all unrecognized tax benefits recorded, substantially all the unrecognized tax benefits would benefit the effective tax rate. With an average statute of limitations of five years, up to $3.1 million of the unrecognized tax benefits could potentially expire in the next 12 months, unless extended by an audit. The Company files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. The U.S. Internal Revenue Service has completed examinations of the Company’s U.S. federal income tax returns through fiscal 2020 . With few exceptions, the Company is no longer subject to state and foreign income tax examinations by tax authorities for years before fiscal 2019. The Company believes it is remote that any adjustment necessary to the reserve for income taxes for the next 12 months will be material. However, it is possible the ultimate resolution of audits or disputes may result in a material change to the Company’s reserve for income taxes, although the quantification of such potential adjustments cannot be made at this time.

Leases

Leases	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Leases	Note 9. Leases The Company enters into operating leases primarily for office, production and warehouse facilities, production and non-production equip ment, automobiles and computer equipment. As of July 31, 2024 and 2023, the Company had no material financing lease obligations. The Company’s operating lease costs were as follows (in millions): Year Ended July 31, 2024 2023 Operating lease cost $ 29.5 $ 24.5 Short-term lease cost 3.0 3.2 Total lease costs $ 32.5 $ 27.7 Supplemental balance sheet information for the Company was as follows (in millions): July 31, Balance Sheet Location 2024 2023 Right-of-use lease assets Other long-term assets $ 59.7 $ 59.4 Current lease liabilities Other current liabilities $ 20.2 $ 17.8 Long-term lease liabilities Other long-term liabilities $ 41.3 $ 42.4 Additional information related to operating leases was as follows: July 31, 2024 2023 Weighted average remaining lease term (years) 3.5 4.2 Weighted average discount rate 4.61 % 3.89 % Remaining payments for operating leases having initial terms of more than one year as of July 31, 2024 were as follows (in millions): 2025 $ 23.0 2026 18.5 2027 12.2 2028 6.9 2029 4.6 Thereafter 2.4 Total future lease payments 67.6 Less imputed interest 6.1 Present value of future lease payments $ 61.5

Earnings Per Share

Earnings Per Share	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Earnings Per Share	Note 10. Earnings Per Share Basic net earnings per share (EPS) is computed by dividing net earnings by the weighted average number of outstanding common shares. Diluted net EPS is computed by dividing net earnings by the weighted average number of outstanding common shares and common share equivalents relating to stock options and other stock incentive plans. Basic and diluted net EPS calculations were as follows (in millions, except per share amounts): Year Ended July 31, 2024 2023 2022 Net earnings $ 414.0 $ 358.8 $ 332.8 Weighted average common shares outstanding Weighted average common shares – basic 120.7 121.8 123.7 Dilutive impact of stock-based awards 1.9 1.8 1.5 Weighted average common shares – diluted 122.6 123.6 125.2 Net EPS – basic $ 3.43 $ 2.95 $ 2.69 Net EPS – diluted $ 3.38 $ 2.90 $ 2.66 Stock options excluded from net EPS calculation 0.0 0.0 1.6

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Jul. 31, 2024
Stockholders' Equity Note [Abstract]
Stockholders' Equity	Note 11. Stockholders’ Equity Share Repurchases In November 2023, the Board of Directors authorized the repurchase of up to 12.0 million shares of common stock under the Company’s stock repurchase plan, replacing the Company’s previous stock repurchase plan dated May 31, 2019. This repurchase authorization is effective until terminated by the Board of Directors. During the year ended July 31, 2024, the Company repurchased 2.5 million shares for $163.3 million. During the year ended July 31, 2023, the Company repurchased 2.5 million shares for $141.8 million. As of July 31, 2024, the Company had remaining authorization to repurchase 10.7 million shares under the November 2023 stock repurchase plan. Treasury stock share activity was as follows: Year Ended July 31, 2024 2023 Balance as of beginning of year 30,528,696 29,089,612 Stock repurchases 2,465,000 2,485,000 Net issuance upon exercise of stock options (1,294,475) (941,837) Issuance under compensation plans (149,329) (84,942) Other activity (16,700) (19,137) Balance as of end of year 31,533,192 30,528,696 Dividends Paid and Declared Dividends paid were $1.02 and 94.0 cents per common share for the years ended July 31, 2024 and 2023, respectively. On July 26, 2024, the Company’s Board of Directors declared a cash dividend in the amount of 27.0 cents per common share, payable August 28, 2024, to stockholders of record as of August 13, 2024.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Accumulated Other Comprehensive Loss	Note 12. Accumulated Other Comprehensive Loss Changes in accumulated other comprehensive loss for the years ended July 31, 2024 and 2023 were as follows (in millions): Foreign Pension Derivative Total Balance as of July 31, 2023, net of tax $ (109.6) $ (67.2) $ 4.3 $ (172.5) Other comprehensive loss before reclassifications and tax (24.2) (9.0) (1) (0.8) (34.0) Tax benefit — 2.3 0.2 2.5 Other comprehensive loss before reclassifications, net of tax (24.2) (6.7) (0.6) (31.5) Reclassifications, before tax — 6.3 (2) 0.3 6.6 Tax expense — (1.5) — (1.5) Reclassifications, net of tax — 4.8 0.3 (3) 5.1 Other comprehensive loss, net of tax (24.2) (1.9) (0.3) (26.4) Balance as of July 31, 2024, net of tax $ (133.8) $ (69.1) $ 4.0 $ (198.9) Balance as of July 31, 2022, net of tax $ (143.6) $ (67.5) $ 5.5 $ (205.6) Other comprehensive income (loss) before reclassifications and tax 34.0 (6.9) (1) (1.9) 25.2 Tax benefit — 2.2 0.5 2.7 Other comprehensive income (loss) before reclassifications, net of tax 34.0 (4.7) (1.4) 27.9 Reclassifications, before tax — 7.5 (2) 0.3 7.8 Tax expense — (2.5) (0.1) (2.6) Reclassifications, net of tax — 5.0 0.2 (3) 5.2 Other comprehensive income (loss), net of tax 34.0 0.3 (1.2) 33.1 Balance as of July 31, 2023, net of tax $ (109.6) $ (67.2) $ 4.3 $ (172.5) (1) In fiscal 2024 and 2023, pension settlement accounting was triggered. In addition, pension curtailment accounting was triggered in fiscal 2024 and 2023. Remeasurements of the Company’s pension obligations resulted in an increase of $9.0 million and $6.9 million in fiscal 2024 and 2023, respectively, to accumulated other comprehensive loss on the Consolidated Balance Sheets, see Note 14. (2) Amounts include reclassifications of $4.8 million and $6.6 million, a foreign currency translation loss of $0.1 million and gain of $1.4 million and net amortization of prior service costs and actuarial losses of $1.4 million and $2.3 million in fiscal 2024 and 2023, respectively. Amounts are included in other income, net in the Consolidated Statements of Earnings, see Note 14. (3) Relates to designated foreign currency forward contracts that were reclassified from accumulated other comprehensive loss on the Consolidated Balance Sheets to net sales, cost of sales and operating expenses in the Consolidated Statements of Earnings, see Note 15.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Stock-Based Compensation	Note 13. Stock-Based Compensation The Company recognizes compensation expense for all stock-based awards based on the grant date fair value of the award. Stock-based awards consist primarily of non-qualified stock options, performance-based awards, restricted stock awards and restricted stock units. Grants related to restricted stock awards and restricted stock units are immaterial. The Company issues treasury shares for stock options and performance-b ased awards. Stock Options The exercise price of options granted is equal to the market price of the Company’s common stock at the date of the grant. Options are generally exercisable for up to ten years from the date of grant and vest in equal increments over three years. Pretax stock-based compensation expense associated with options was $14.2 million, $12.4 million and $11.6 million for the years ended July 31, 2024, 2023 and 2022, respectively. Fair value is calculated using the Black-Scholes option pricing model. The weighted average fair value for options granted during the years ended July 31, 2024, 2023 and 2022 was $19.00, $15.67 and $14.24 per share, respectively. The fair value of these awards was determined using the following inputs: Year Ended July 31, 2024 2023 2022 Risk-free interest rate 3.8% - 4.6% 3.8% - 4.2% 1.2% - 1.8% Expected volatility 26.8% - 27.2% 26.8% - 27.5% 26.0% - 27.0% Expected dividend yield 1.6 % 1.6 % 1.6 % Expected life: Director grants 8 years 8 years 8 years Officer grants 7 years 7 years 7 years Non-officer grants 7 years 7 years 7 years Option activity was as follows: Options Weighted Balance outstanding as of July 31, 2023 6,777,407 $ 47.80 Granted 809,278 59.95 Exercised (1,372,191) 42.30 Expired/forfeited (51,438) 54.14 Balance outstanding as of July 31, 2024 6,163,056 $ 50.57 The total intrinsic value of options exercised during the years ended July 31, 2024, 2023 and 2022 was $35.9 million, $20.2 million and $7.8 million, respectively. The number of shares authorized as of July 31, 2024 for outstanding options and future grants was 11,954,309. Forfeited options are recorded as an offset to operating expenses in the Consolidated Statements of Earnings in the period in which they occur. Outstanding and exercisable stock options as of July 31, 2024 were as follows: Range of Exercise Prices Number Weighted Weighted Number Weighted Weighted $28.00 to $37.99 494,960 1.3 $ 29.54 494,960 1.3 $ 29.54 $38.00 to $43.99 620,682 2.3 42.25 620,682 2.3 42.25 $44.00 to $49.99 1,255,623 4.9 45.97 1,255,623 4.9 45.97 $50.00 to $55.99 1,538,333 6.8 51.33 977,432 6.0 51.58 $56.00 and above 2,253,458 7.0 59.52 1,156,389 5.5 59.23 6,163,056 5.6 $ 50.57 4,505,086 4.5 $ 48.27 As of July 31, 2024, the aggregate intrinsic value of stock options outstanding and exercisable was $149.5 million and $119.6 million, respectively. For the year ended July 31, 2024, activity for non-vested stock options that contain vesting provisions was as follows: Options Weighted Balance outstanding as of beginning of year 1,783,711 $ 14.27 Granted 809,278 19.00 Vested (893,885) 13.34 Forfeited (41,134) 16.61 Balance outstanding as of end of year 1,657,970 $ 17.02 As of July 31, 2024, there was $8.6 million of total unrecognized compensation expense related to non-vested stock options, which is expected to be recognized over the remaining vesting period during fiscal 2025, 2026 and 2027. Performance-Based Awards Performance-based awards are payable in common stock and are based on a formula that measures Company performance over a three year period. These awards are settled after three years with payouts ranging from 0% to 200% of the target award depending on achievement. Pretax performance-based awards expense was $5.8 million, $6.3 million and $7.2 million for the years ended July 31, 2024, 2023 and 2022, respectively. The weighted average grant date fair value related to the Company’s performance-based awards was as follows: Year Ended July 31, 2024 2023 2022 Weighted average grant date fair value $ 59.66 $ 50.89 $ 59.40 Performance-based awards for non-vested activity were as follows: Performance Shares Weighted Balance outstanding as of July 31, 2023 194,761 $ 54.46 Granted 114,800 59.66 Vested (81,661) 59.40 Forfeited — — Balance outstanding as of July 31, 2024 227,900 $ 55.31

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Jul. 31, 2024
Retirement Benefits, Description [Abstract]
Employee Benefit Plans	Note 14. Employee Benefit Plans Defined Benefit Pension Plans The Company has defined benefit pension plans for certain hourly and salaried employees. They consist of plans in the U.S., Belgium, Germany, Mexico and the United Kingdom. These plans generally provide pension benefits based on years of service and compensation level. Components of net periodic pension costs other than the service cost component are included in other income, net in the Consolidated Statements of Earnings. Net periodic pension costs for the Company’s pension plans were as follows (in millions): Year Ended July 31, 2024 2023 2022 Net periodic pension costs Service cost $ 5.2 $ 6.7 $ 6.9 Interest cost 20.4 17.0 10.6 Expected return on assets (25.7) (25.3) (24.8) Prior service cost amortization 0.1 — 0.2 Actuarial loss amortization 1.5 2.1 6.9 Settlement loss 4.9 5.5 3.0 Curtailment loss 0.2 0.2 — Net periodic pension costs 6.6 6.2 2.8 Other changes recognized in other comprehensive (loss) income: Prior service cost 0.1 (0.4) — Net actuarial (loss) gain (9.1) (5.9) (1.3) Amortization of prior service cost 0.3 0.2 0.3 Amortization of net actuarial loss 6.4 7.7 9.9 Total recognized in other comprehensive (loss) income (2.3) 1.6 8.9 Total recognized in net periodic pension costs and other comprehensive (loss) income $ (8.9) $ (4.6) $ 6.1 The changes in projected benefit obligations, fair value of plan assets and funded status of the Company’s pension plans for the years ended July 31, 2024 and 2023 were as follows (in millions): Year Ended July 31, 2024 2023 Change in projected benefit obligation Projected benefit obligation, beginning of year $ 401.1 $ 442.6 Service cost 5.2 6.7 Interest cost 20.4 17.0 Plan amendments (0.1) 0.2 Participant contributions 0.8 0.7 Actuarial (gain) loss 11.7 (42.0) Foreign currency exchange rates (1.8) 9.2 Settlements paid (15.6) (17.0) Acquisition 0.6 1.2 Benefits paid (18.6) (17.5) Projected benefit obligation, end of year 403.7 401.1 Change in fair value of plan assets Fair value of plan assets, beginning of year 416.0 459.8 Actual return on plan assets 28.4 (22.1) Company contributions 2.8 2.6 Participant contributions 0.8 0.7 Foreign currency exchange rates (1.1) 8.3 Settlements paid (15.6) (17.0) Acquisition 0.6 1.2 Benefits paid (18.6) (17.5) Fair value of plan assets, end of year 413.3 416.0 Funded status of plans, end of year $ 9.6 $ 14.9 Amounts recognized on the Consolidated Balance Sheets Other long-term assets $ 35.8 $ 34.7 Other current liabilities (1.5) (1.7) Other long-term liabilities (24.7) (18.1) Net recognized asset $ 9.6 $ 14.9 T he ne t overfunded status of $9.6 million and $14.9 million as of July 31, 2024 and 2023, respectively, is recognized on the Consolidated Balance Sheets. The pension-related accumulated other comprehensive loss as of July 31, 2024 and 2023, prior to the consideration of income taxes, was $111.3 million and $109.0 million, respectively, and consisted primarily of unrecognized actuarial losses. The accumulated benefit obligation for all defined benefit pension plans was $385.1 million and $384.4 million as of July 31, 2024 and 2023, respectively. The increase in the accumulated benefit obligation during fiscal 2024 is due to actuarial losses. Pension settlement accounting was triggered in fiscal 2024 and 2023 as a result of the amount of lump sum distributions in the defined benefit pension plans exceeding the service and interest cost threshold. The projected benefit obligation and fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets were $75.3 million and $49.1 million, respectively, as of July 31, 2024 and $73.5 million and $53.7 million, respectively, as of July 31, 2023. The projected benefit obligation, accumulated benefit obligation and fair value of plan assets for pension plans with accumulated benefit obligations in excess of plan assets were $17.7 million, $16.4 million and $7.3 million, respectively, as of July 31, 2024 and $15.0 million, $15.0 million and $5.0 million, respectively, as of July 31, 2023. Assumptions The significant assumptions used in determining the actuarial present value of the projected benefit obligation were as follows: Year Ended July 31, 2024 2023 U.S. plans Discount rate 5.44 % 5.58 % Rate of compensation increase N/A N/A Non-U.S. plans Discount rate 4.33 % 4.80 % Rate of compensation increase 3.05 % 3.12 % The weighted average discount rates, expected returns on plan assets and rates of increase in future compensation levels used to determine the net periodic pension costs were as follows: Year Ended July 31, 2024 2023 2022 U.S. plans Discount rate 5.58 % 4.62 % 2.55 % Expected rate of return on plan assets 6.16 % 5.66 % 5.41 % Rate of compensation increase N/A N/A N/A Non-U.S. plans Discount rate 4.80 % 3.26 % 1.60 % Expected rate of return on plan assets 5.01 % 4.39 % 3.40 % Rate of compensation increase 3.05 % 3.12 % 2.99 % Discount Rates The Company’s objective in selecting a discount rate is to select the best estimate of the rate at which the benefit obligations could be effectively settled on the measurement date, taking into account the nature and duration of the benefit obligations of the plan. In making this best estimate, the Company looks at the rates of return on high-quality fixed-income investments currently available and expected to be available, during the period to maturity of the benefits. This process includes assessing the universe of bonds available on the measurement date with a quality rating of Aa or better. Similar appropriate benchmarks are used to determine the discount rate for the non-U.S. plans. Expected Long-Term Rate of Return on Plan Assets The Company considers historical returns and future expected returns for each asset class, as well as the target asset allocation to develop the assumption for each of its U.S. pension plans. The assumption for non-U.S. pension plans reflects the investment allocation and expected total portfolio returns specific to each plan and country. Mortality Rates The Company’s actuary uses the Pri-2012 mortality table issued by the Society of Actuaries during the pre-retirement period and the Mercer Industry Longevity Experience Study (MILES) table for the Auto, Industrial Goods and Transportation industry group for post-retirement mortality, both reflecting the Scale MMP-2021 mortality improvement projection scale for its U.S. pension plans. These assumptions were used for determining the benefit obligations as of July 31, 2024 and for developing the annual expense for its U.S. pension plans for the fiscal year ending July 31, 2025. The Company follows the local actuaries’ recommendations for non-U.S. pension plans. Service and Interest Costs The Company uses a full yield curve approach to estimate service and interest costs by applying specific spot rates along the yield curve used to determine the benefit obligation of relevant projected cash outflows. This method provides a precise measurement of service and interest costs by aligning the timing of the plans’ liability cash flows to the corresponding spot rate on the yield curve. Investments Global Equity Securities Global equity securities consist primarily of publicly traded U.S. and non-U.S. equities, mutual funds, collective investment trusts, diversified growth investment funds and private equity. Publicly traded equities and index funds are valued at the closing price reported in the active market in which the individual securities are traded. Private equity consists of interests in partnerships that invest in U.S. and non-U.S. equity and debt securities. This may include a diversified mix of partnership interests including buyouts, restructured or distressed debt, growth equity, mezzanine or subordinated debt, real estate, special situation partnerships and venture capital investments. Interests in these funds are valued at net asset value (NAV). Fixed Income Securities Fixed income securities consist primarily of investment and non-investment grade debt securities, debt securities issued by the U.S. Treasury, multi-asset credit investment funds and exchange-traded funds. Government, corporate and other bonds and notes, interest rate and inflation swaps, physical inflation-linked and nominal gilts, synthetic gilts, money market instruments and cash are valued at the closing price reported if they are traded on an active market or if they are traded at yields currently available on comparable securities of issuers with similar credit ratings. Fixed income securities also include smaller allocations to alternative investments, private equity and alternative fixed income investments. Alternative investments consist primarily of private placement funds, private equity investments and alternative fixed income-like investments. Private equity consists of interests in partnerships that invest in U.S. and non-U.S. equity and debt securities. This may include a diversified mix of partnership interests including buyouts, restructured or distressed debt, growth equity, mezzanine or subordinated debt, real estate, special situation partnerships and venture capital investments. Alternative fixed income securities consist primarily of private partnership interests in hedge funds. Interests in these funds are valued at NAV, which is determined by the administrator or custodian of the fund based on the fair value of the underlying assets owned by the fund less its liabilities. Insurance Contracts Insurance contracts are individual contracts whereby an insurance company offers a guaranteed minimum interest return. The Company does not have any influence on the investment decisions made by the insurer. European insurers, in general, are strictly regulated by an external control mechanism and have to invest for their guaranteed interest products within certain boundaries. Typically, they have a strategic asset allocation with 80% to 90% fixed income products and 10% to 20% equity-type products, including real estate. Real Assets Funds Real assets funds consist of interests in partnerships that invest in private real estate and commodities investments. Interests in partnerships are valued using NAV. Fair Value of Plan Assets Fair value measurements of plan assets are reported in one of three levels based on the lowest level of significant input used. For Level 1, inputs to the fair value measurement are quoted prices in active markets for identical assets or liabilities. For Level 2, inputs to the fair value measurement include quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. For Level 3, inputs to the fair value measurement are unobservable inputs or are based on valuation techniques. The estimated fair value of pension plan assets and their respective levels in the fair value hierarchy by asset category were as follows (in millions): Level 1 Level 2 Level 3 Total Balances as of July 31, 2024 Cash and cash equivalents $ 2.4 $ 0.5 $ — $ 2.9 Global equity securities 58.2 54.5 — 112.7 Fixed income securities 80.4 128.0 — 208.4 Insurance contracts — — 42.7 42.7 Total investments in the fair value hierarchy $ 141.0 $ 183.0 $ 42.7 366.7 Investments using NAV as practical expedient 44.2 Total investment, at fair value 410.9 Accrued income 2.4 Total assets $ 413.3 Balances as of July 31, 2023 Cash and cash equivalents $ 3.6 $ 0.7 $ — $ 4.3 Global equity securities 61.2 55.7 — 116.9 Fixed income securities 90.1 117.2 — 207.3 Insurance contracts — — 41.3 41.3 Total investments in the fair value hierarchy $ 154.9 $ 173.6 $ 41.3 369.8 Investments using NAV as practical expedient 46.2 Total investment, at fair value $ 416.0 Certain investments, valued at NAV, had the following unfunded commitments and/or redemption restrictions (in millions): July 31, 2024 July 31, 2023 NAV Unfunded Commitments NAV Unfunded Commitments Redemption Frequency Redemption Notice (Days) Global equity securities $ 31.1 $ 1.8 $ 33.6 $ 1.8 Daily 0 - 5 Fixed income securities 10.2 — 9.5 — Daily, Weekly and Quarterly 0 - 60 Real asset funds 2.9 4.2 3.1 4.2 Not eligible N/A Total U.S. assets $ 44.2 $ 6.0 $ 46.2 $ 6.0 The changes in the fair values of the pension plans’ Level 3 assets were as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ 41.3 $ 35.4 $ 37.7 Unrealized gains 3.4 2.7 3.5 Foreign currency exchange (0.8) 3.0 (5.6) Purchases and sales, net (1.2) 0.2 (0.2) Balance as of end of year $ 42.7 $ 41.3 $ 35.4 Investment Policies and Strategies For U.S. pension plans, t he Company uses a total return on investment approach to achieve a long-term return on plan assets, with what the Company believes to be a prudent level of risk for the purpose of meeting its retirement income commitments to employees. The U.S. pension plans’ investments are diversified to assist in managing risk. During the year ended July 31, 2024, the Company’s asset allocation was as follows: Salaried Pension Plan Hourly Pension Plan Global equity securities 33 % 32 % Fixed income securities 65 67 Real asset funds 1 — Cash and cash equivalents 1 1 Total 100 % 100 % The target allocation guidelines are determined in conjunction with the Company’s investment consultant and through the use of modeling the risk/return trade-offs among asset classes utilizing assumptions about expected annual return, expected volatility/standard deviation of returns and expected correlations with other asset classes. For non-U.S. plans, the general investment objectives are to maintain a suitably diversified portfolio of secure assets with appropriate liquidity that will generate income and capital growth to meet, together with any new contributions from members and the Company, the cost of current and future benefits. Investment policy and performance is measured and monitored on an ongoing basis. Estimated Contributions and Future Payments The Company’s general funding policy is to make at least the minimum required contributions as required by applicable regulations, plus any additional amounts it determines to be appropriate. The Company made contributions of $2.8 million to its pension plans during the year ended July 31, 2024. Future required pension plan contributions may change significantly depending on the actual rate of return on plan assets, discount rates and regulatory requirements. Estimated future benefit required payments for the Company’s pension plans as of July 31, 2024 were as follows (in millions): 2025 $ 27.8 2026 $ 27.6 2027 $ 28.6 2028 $ 28.0 2029 $ 31.7 2030-2034 $ 158.7 Retirement Savings The Company provides a contributory employee savings plan to U.S. employees that permits participants to make contributions by salary reduction pursuant to section 401(k) of the Internal Revenue Code. For eligible employees, employee contributions of up to 50% of compensation are matched at a rate equaling 100% of the first 3% contributed and 50% of the next 2% contributed. In addition, the Company contributes 3% of compensation annually for eligible employees. Total contribution expense for this plan was $32.7 million, $28.6 million and $27.2 million for the years ended July 31, 2024, 2023 and 2022, respectively. Deferred Compensation and Other Benefit Plans The Company provides various deferred compensation and other benefit plans to certain executives. The deferred compensation plan allows eligible employees to defer the receipt of all or a portion of their cash bonus and other stock-related compensation and up to 75% of their salary to future periods. Other benefit plans are provided to supplement the benefits for a select group of highly compensated individuals that are reduced because of compensation limitations set by the Internal Revenue Code. The Company has recorded a liability of $1.2 million and $1.9 million as of July 31, 2024 and 2023, respectively, related primarily to its deferred compensation plans.

Derivative Instruments and Hedg

Derivative Instruments and Hedging	12 Months Ended
	Jul. 31, 2024
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments and Hedging	Note 15. Derivative Instruments and Hedging Derivative Fair Value Measurements The Company enters into derivative instrument agreements, including foreign currency forward contracts and net investment hedges, to manage risk in connection with changes in foreign currency. The Company only enters into derivative instrument agreements with counterparties who have highly rated credit. There is risk the counterparties to derivative contracts will fail to meet their contractual obligations. In order to mitigate counterparty credit risk, the Company only enters into contracts with carefully selected financial institutions based upon their credit ratings and certain other financial factors. Contract provisions may require the posting of collateral or settlement of the contracts for various reasons, including if the Company’s credit ratings are downgraded below its investment grade credit rating by any of the major credit agencies or for cross default contractual provisions if there is a failure under other financing arrangements related to payment terms or covenants. As of July 31, 2024 and 2023, no collateral was posted. The Company does not enter into derivative instrument agreements for trading or speculative purposes. For discussion on the fair value of the Company’s derivatives, see Note 16. Foreign Currency Forward Contracts - Cash Flow Hedges and Derivatives Not Designated as Hedging Instruments The Company buys materials from foreign suppliers. Those transactions can be denominated in those suppliers’ local currency. The Company also sells to customers in foreign countries. Those transactions can be denominated in those customers’ local currency. Both of these transaction types can create volatility in the Company’s financial statements. The Company uses foreign currency forward contracts to manage those exposures and fluctuations. These contracts generally mature in 12 months or less, which is consistent with the forecasts of the related purchases and sales. Certain contracts are designated as cash flow hedges, whereas the remaining contracts, most of which are related to certain intercompany transactions which offset balance sheet exposure, are not designated as hedging instruments. The total notional amounts of the foreign currency forward contracts designated as hedges as of July 31, 2024 and 2023 were $32.3 million and $84.9 million, respectively. The total notional amounts of the foreign currency forward contracts not designated as hedges as of July 31, 2024 and 2023 were $249.7 million and $147.5 million , respectively. Changes in the fair value of the Company’s designated hedges are reporte d in accumulated other comprehensive loss on the Consolidated Balance Sheets until the related transaction occurs, see Note 12. Designated hedges are recognized as a component of net sales, cost of sales, operating expenses and other income, net in the Consolidated Statements of Earnings upon occurrence of the related hedged transaction. H edges which are not designated are recognized in other income, net in the Consolidated Statements of Earnings along with the related hedged transactions. Changes in the fair value of hedges which are not designated, are recognized in other income, net in the Consolidated Statements of Earnings. Amounts related to foreign currency forward contracts designated as hedges are expected to be reclassified into earnings during the next 12 months based upon the timing of inventory purchases and sales. Net Investment Hedges The Company uses fixed-to-fixed cross-currency swap agreements to hedge its exposure to adverse foreign currency exchange rate movements for its operations in Europe. The Company has elected the spot method for designating these contracts as net investment hedges. The total notional amount of net investment hedges as of July 31, 2024 and 2023 was €80 million , or $88.8 million. The maturity dates range from 2027 to 2029 . Gains and losses resulting from a change in fair value of the net investment hedge are offset by gains and losses on the underlying foreign currency exposure and are included in accumulated other comprehensive loss on the Consolidated Balance Sheets. Amounts related to excluded components associated with the net investment hedge are expected to be reclassified into earnings in interest expense in the Consolidated Statements of Earnings through their maturity. Interest Rate Swaps - Cash Flow Hedges As of July 31, 2024 and 2023, there were no outstanding interest rate swap arrangements. Cash Flows Cash flows from derivative transactions are recorded in operating activities in the Consolidated Statements of Cash Flows.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 16. Fair Value Measurements Fair value measurements of financial instruments are reported in one of three levels based on the lowest level of significant input used. For Level 1, inputs to the fair value measurement are quoted prices in active markets for identical assets or liabilities. For Level 2, inputs to the fair value measurement include quoted prices in active markets for similar assets or liabilities, quoted prices for identical or similar assets or liabilities in markets that are not active and inputs other than quoted prices that are observable for the asset or liability, either directly or indirectly. For Level 3, inputs to the fair value measurement are unobservable inputs or are based on valuation techniques. Short-Term Financial Instruments As of July 31, 2024 and 2023, the carrying va lues of cash and cash equivalents, ac counts receivable, short-term borrowings and accounts payable approximate fair value because of the short-term nature of these instrume nts and a re classified as Level 1 in the fair value hierarchy. Long-Term Debt As of July 31, 2024, the estimated fair v alues of fixed interest rate long-term debt were $267.7 million compared to the carrying values of $300.0 million . As of July 31, 2023, the estimated fair values of fixed interest rate long-term debt were $378.9 million compared to the carrying values of $425.0 million. The fair values are estimated by discounting the projected cash flows using the interest rates at which similar amounts of debt could currently be borrowed. The carrying values of total variable interest rate long-term debt were $209.9 million and $198.4 million as of July 31, 2024 and 2023, respectively and approximate their fair values. Long-term debt is classified as Level 2 in the fair value hierarchy. Investment in Joint Ventures The Company holds investments in joint ventures, which are accounted for as equity method investments at fair value and are included in other long-term assets on the Consolidated Balance Sheets. The aggregate carrying amount of these investments was $26.9 million and $24.4 million as of July 31, 2024 and 2023, respectively. These equity method investments are measured at fair value on a non-recurring basis. The fair value of the Company’s equity method investments has not been adjusted as there have been no triggering events or changes in circumstance that would have had an adverse impact on the value of these investments. In the event these investments are required to be measured, they would fall within Level 3 of the fair value hierarchy due to the use of significant unobservable inputs to determine fair value, as the investments are in privately-held entities. Derivative Fair Value Measurements The fair values of the Company’s foreign currency forward contracts, net investment hedges and interest rate swaps reflect the amounts that would be received to sell the assets or paid to transfer the liabilities in an orderly transaction between market participants at the measurement date (exit price). The fair values are based on inputs other than quoted prices that are observable for the asset or liability and are determined by standard calculations and models that use readily observable market parameters. These inputs include foreign currency exchange rates and interest rates. Industry standard data providers are the primary source for forward and spot rate information for both interest rates and foreign currency exchange rates. The fair values of the Company’s foreign currency forward contracts, net investment hedges and interest rate swaps are classified as Level 2 in the fair value hierarchy. For discussion of the Company’s derivatives and hedging, see Note 15. Fair Value of Derivative Contracts The fair value of the Company’s derivative contracts, recorded on the Consolidated Balance Sheets, was as follows (in millions): Assets Liabilities July 31, July 31, Balance Sheet Location 2024 2023 2024 2023 Designated as hedging instruments Foreign currency forward contracts Other current assets, other current liabilities $ 0.1 $ 0.6 $ — $ 0.1 Net investment hedges Other current assets, other long-term assets 3.7 3.6 — — Total designated 3.8 4.2 — 0.1 Not designated as hedging instruments Foreign currency forward contracts Other current assets, other current liabilities 1.0 0.7 0.3 1.4 Total not designated 1.0 0.7 0.3 1.4 Total $ 4.8 $ 4.9 $ 0.3 $ 1.5 Fair Value of Contingent Consideration The fair value of the contingent consideration liability is determined using a probability-weighted discounted cash flow method. This fair value measurement is based on unobservable inputs in the market and thus, represents a Level 3 measurement within the fair value hierarchy. This analysis reflects the contractual terms of the purchase agreement (e.g., potential payment amounts, length of measurement periods, manner of calculating any amounts due) and utilizes assumptions with regard to future cash flows, probabilities of achieving such future cash flows and a discount rate. Depending on the contractual terms of the purchase agreement, the probability of achieving future cash flows or earnings generally represent the only significant unobservable inputs. The contingent consideration liability is measured at fair value each reporting period and changes in estimates of fair value are recognized in earnings. A reconciliation of the fair value of the Company’s contingent consideration liability that use unobservable inputs was as follows (in millions): Balance as of July 31, 2023 $ 25.0 Issuances 1.0 Settlements (2.0) Adjustments to fair value (2.2) Balance as of July 31, 2024 $ 21.8 Maximum potential payout $ 29.7 Balance as of July 31, 2022 $ 24.7 Issuances — Adjustments to fair value 0.3 Balance as of July 31, 2023 $ 25.0 Maximum potential payout $ 30.7

Guarantees

Guarantees	12 Months Ended
	Jul. 31, 2024
Product Warranties Disclosures [Abstract]
Guarantees	Note 17. Guarantees Letters of Credit The Company has letters of credit which guarantee payment to third parties in the event the Company is in breach of contract terms as detailed in each letter of credit. The outstanding debt contingent liability for standby letters of credit was as follows (in millions): Year Ended July 31, 2024 2023 Contingent liability for standby letters of credit issued under the Company’s revolving credit facility $ 7.5 $ 7.5 Amounts drawn for letters of credit under the Company’s revolving credit facility $ — $ — Advanced Filtration Systems Inc. (AFSI) The Company has an unconsolidated joint venture, AFSI, established by the Company and Caterpillar Inc. (Caterpillar) in 1986. AFSI designs and manufactures high-efficiency fluid filters use d in Caterpillar’s machinery worldwide. The Company and Caterpillar equally own the shares of AFSI and both companies guarantee certain debt and banking services, including credit and debit cards, merchant processing and treasury management services, of the joint venture. The Company accounts for AFSI as an equity method investment. The outstanding debt relating to AFSI, of which the Company guarantees half, was $51.0 million and $59.6 million as of July 31, 2024 and 2023, respectively. AFSI has $63.0 million in a revolving credit facility which expires on July 31, 2027 and $17.0 million in an additional multi-currency revolving credit facility which terminates upon notification of either party.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Jul. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 18. Commitments and Contingencies The Company records provisions when it is probable a liability has been incurred and the amount of the loss can be reasonably estimated. Claims and litigation are reviewed quarterly and provisions are taken or adjusted to reflect the status of a particular matter. The Company believes the estimated liability in its Consolidated Financial Statements for claims or litigation is adequate and appropriate for the probable and estimable outcomes. Liabilities recorded were not material to the Company’s financial position, results of operations or liquidity. The Company believes it is remote that the settlement of any of the currently identified claims or litigation will be materially in excess of what is accrued. Contingent Compensation and Consideration Purilogics The Company’s acquisition purchase agreement with Purilogics includes deferred payment provisions representing potential milestone payments for its former owners. The provisions are made up of two general types of arrangements, contingent compensation and contingent consideration. The contingent compensation arrangement is contingent on the former owner’s future employment with the Company and the related amounts are recognized over the required employment period. The contingent consideration is not contingent on employment and is recorded as purchase consideration in both other current and other long-term liabilities on the Consolidated Balance Sheets at the time of the initial acquisition based on the fair value of the estimated liability. The amounts are paid over a two The total contingent compensation arrangement liability wa s $2.1 million as of July 31, 2024, which was included in accrued employee compensation and related taxes on the Consolidated Balance Sheets. The total contingent compensation arrangement liability was $1.1 million as of July 31, 2023, which was included in other long-term liabilities on the Consolidated Balance Sheets. The maximum payout of the contingent compensation arrangement upon completion of the future performance periods was $3.0 million, inclusive of the $2.1 million and $1.1 million accrued as of July 31, 2024 and 2023, respectively. The Company primarily determines the contingent consideration liability based on the forecasted probability of achieving certain milestones. The contingent consideration liability is measured at fair value each reporting period and changes in estimates of fair value are recognized in earnings. The total contingent consideration liability was $19.0 million and $23.2 million as of July 31, 2024 and 2023, respectively and was included in other current and other long-term liabilities on the Consolidated Balance Sheets. The maximum payout of the contingent consideration was $27.0 million and $29.0 million as of July 31, 2024 and 2023, respectively, inclusive of the $19.0 million and $23.2 million accrued as of July 31, 2024 and 2023, respectively. The total contingent consideration paid was $2.0 million as of July 31, 2024, consisting of $2.0 million paid during fiscal 2024. For additional discussion regarding the fair value of the Company’s contingent consideration liability, see Note 16. Other Acquisitions For other acquisitions, the total contingent compensation arrangement liability was $0.3 million and $0.9 million as of July 31, 2024 and July 31, 2023 respectively, which was included in other long-term liabilities on the Consolidated Balance Sheets. The maximum payout of the contingent compensation arrangements upon completion of the future performance periods was $0.8 million as of July 31, 2024, which will expire in 2 to 4 years. This is inclusive of the $0.3 million accrued as of July 31, 2024. The total contingent consideration liability was $2.8 million as of July 31, 2024 and was included in other current liabilities on the Consolidated Balance Sheets. The total contingent consideration liability was $1.7 million as of July 31, 2023 and was included in other long-term liabilities on the Consolidated Balance Sheets. The maximum payout of the contingent consideration was $2.8 million and $1.7 million as of July 31, 2024 and 2023, respectively. Warranty Reserves The Company estimates warranty expense on certain products at the time of sale using quantitative measures based on historical warranty claim experience and evaluation of specific customer warranty i ssues

Segment Reporting

Segment Reporting	12 Months Ended
	Jul. 31, 2024
Segment Reporting, Measurement Disclosures [Abstract]
Segment Reporting	Note 19. Segment Reporting The Company’s reportable segments are: Mobile Solutions, Industrial Solutions and Life Sciences. The organizational structure also includes Corporate and Unallocated which includes interest expense and certain corporate expenses determined to be non-allocable to the segments, such as restructuring charges and business development expenses. The Company determines its operating segments consistent with the manner in which it manages its operations and evaluates performance for internal review and decision-making. In fiscal 2024, Corporate and Unallocated included a charge of $6.4 million related to restructuring, see Note 20. The Mobile Solutions segment is organized based on a combination of customers and products and consists of the Off-Road, On-Road and Aftermarket business units. Within these business units, products consist of replacement filters for both air and liquid filtration applications and filtration housings for new equipment production and systems related to exhaust and emissions. Applications include air filtration systems, fuel, lube and hydraulic systems, emissions systems and sensors, indicators and monitoring systems. Mobile Solutions sells to original equipment manufacturers (OEMs) in the construction, mining, agriculture and transportation end markets and to independent distributors and OEM dealer networks. The Industrial Solutions segment is organized based on product type and consists of Industrial Air Filtration, Industrial Gasses, Industrial Hydraulics, Power Generation and Aerospace and Defense products. These products are further organized by the Industrial Filtration Solutions and Aerospace and Defense business units. Within our industrial portfolio, Donaldson provides the widest product offering in the market to industrial customers consisting of equipment, ancillary components, replacement parts, performance monitoring and service globally, that cost-effectively enhances productivity and manufacturing efficiency. Industrial Air Filtration, Industrial Gasses and Industrial Hydraulics products consist of dust, fume and mist collectors, compressed air and industrial gasses purification systems, hydraulic and lubricated rotating filtration applications as well as gas and liquid filtration for industrial processes. Power Generation products consist of air inlet systems and filtration sold to gas compression, power generation and natural gas liquification industries. Aerospace and Defense products consist of air, fuel, lubrication and hydraulic filtration for fixed-wing and rotorcraft aerospace applications and ground defense vehicle and naval platforms. Industrial Solutions businesses sell through multiple channels which include OEMs, distributors and direct-to-consumer in some markets. The Life Sciences segment is organized by end market and consists of the Bioprocessing Equipment and Consumables, Food and Beverage, Vehicle Electrification and Medical Device, Microelectronics and Disk Drive markets. Within these markets, products consist of micro-environment gas and liquid filtration for food and beverage and industrial processes, bioprocessing equipment, including bioreactors and fermenters, bioprocessing consumables including chromatography devices, reagents and filters, polytetrafluoroethylene membrane-based products, as well as specialized air and gas filtration systems for applications including hard disk drives, semiconductor manufacturing, sensors, battery systems and powertrain components. Life Sciences primarily sells to large OEMs and directly to various end users requiring cell growth, separation, purification, high purity filtration and device protection. The Company has manufacturing facilities that serve multiple reportable segments. As such, capital expenditure information by reportable segment has not been provided because the Company does not produce or utilize such information internally. In addition, although depreciation and amortization expense is a component of each reportable segment’s operating results, it is not discretely identifiable. The Company is an integrated enterprise, characterized by substantial intersegment cooperation, cost allocations and sharing of assets. Therefore, the Company does not represent these segments, if operated independently, would report earnings before income taxes and other financial information as stated below. Segment details were as follows (in millions): Mobile Solutions Segment Industrial Solutions Segment Life Sciences Segment Corporate and Total Year ended July 31, 2024 Net sales $ 2,250.8 $ 1,066.5 $ 269.0 $ — $ 3,586.3 Equity earnings in unconsolidated affiliates $ 7.3 $ 0.1 $ — $ — $ 7.4 Earnings (loss) before income taxes $ 404.5 $ 198.8 $ (10.4) $ (57.6) $ 535.3 Assets $ 1,339.5 $ 821.7 $ 512.1 $ 241.0 $ 2,914.3 Equity investments in unconsolidated affiliates $ 26.8 $ 0.1 $ — $ — $ 26.9 Year ended July 31, 2023 Net sales $ 2,174.8 $ 1,014.7 $ 241.3 $ — $ 3,430.8 Equity earnings in unconsolidated affiliates $ 3.6 $ — $ — $ — $ 3.6 Earnings (loss) before income taxes $ 330.4 $ 186.2 $ 9.9 $ (57.8) $ 468.7 Assets $ 1,243.8 $ 788.1 $ 513.8 $ 224.8 $ 2,770.5 Equity investments in unconsolidated affiliates $ 24.2 $ 0.2 $ — $ — $ 24.4 Year ended July 31, 2022 Net sales $ 2,126.5 $ 901.0 $ 279.1 $ — $ 3,306.6 Equity earnings in unconsolidated affiliates $ 1.7 $ — $ — $ — $ 1.7 Earnings (loss) before income taxes $ 293.8 $ 133.0 $ 64.9 $ (53.3) $ 438.4 Assets $ 1,319.4 $ 816.0 $ 267.8 $ 197.1 $ 2,600.3 Equity investments in unconsolidated affiliates $ 22.3 $ 0.1 $ — $ — $ 22.4 Net sales by business unit were as follows (in millions): Year Ended July 31, 2024 2023 2022 Mobile Solutions segment Off-Road $ 380.8 $ 428.7 $ 390.5 On-Road 139.8 145.8 136.1 Aftermarket 1,730.2 1,600.3 1,599.9 Total Mobile Solutions segment 2,250.8 2,174.8 2,126.5 Industrial Solutions segment Industrial Filtration Solutions 901.1 872.2 780.5 Aerospace and Defense 165.4 142.5 120.5 Total Industrial Solutions segment 1,066.5 1,014.7 901.0 Life Sciences segment Total Life Sciences segment 269.0 241.3 279.1 Total Company $ 3,586.3 $ 3,430.8 $ 3,306.6 Net sales, generally disaggregated by location where the customer’s order was received and property, plant and equipment, net by geographic region were as follows (in millions): Net Sales Property, Plant and Equipment, Net Year ended July 31, 2024 U.S. and Canada $ 1,583.1 $ 209.7 EMEA 1,012.9 199.6 APAC 601.5 75.5 LATAM 388.8 160.7 Total $ 3,586.3 $ 645.5 Year ended July 31, 2023 U.S. and Canada $ 1,464.7 $ 219.7 EMEA 1,007.8 202.4 APAC 608.8 76.5 LATAM 349.5 154.3 Total $ 3,430.8 $ 652.9 Year ended July 31, 2022 U.S. and Canada $ 1,336.8 $ 218.1 EMEA 963.6 184.3 APAC 669.0 59.5 LATAM 337.2 132.5 Total $ 3,306.6 $ 594.4 Concentrations There were no customers that accounted for over 10% of net sales for the years ended July 31, 2024, 2023 or 2022. There were no customers that accounted for over 10% of gross accounts receivable as of July 31, 2024 or 2023.

Restructuring

Restructuring	12 Months Ended
	Jul. 31, 2024
Restructuring and Related Activities [Abstract]
Restructuring	Note 20. Restructuring During the fourth quarter of fiscal 2024, the Company initiated global footprint optimization and cost reduction actions to further improve its operating and manufacturing cost structure, primarily in EMEA. These activities resulted in restructuring expenses, primarily related to severance, of $6.4 million. Charges of $3.8 million were included in cost of sales and $2.6 million were included in operating expenses in the Consolidated Statement of Earnings for the year ended July 31, 2024. As of July 31, 2024, $6.4 million of accrued expenses were included in accrued employee compensation and related taxes in the Consolidated Balance Sheet. Estimated future costs associated with actions related to this restructuring initiative are not included due to the Company’s inability to reasonably quantify the anticipated restructuring charges. During fiscal 2023, the Company announced a company-wide organizational redesign to further support the Company’s growth strategies and better serve its customers. I n conjunction with the organizational redesign, the Company recorded $21.8 million of charges consisting of $15.3 million of severance charges and other organizational redesign costs and $6.5 million of costs mainly associated with the exiting of a lower-margin customer program and a lower-margin product. Charges of $2.9 million were included in cost of sales were included in selling, general and administrative expenses

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Pay vs Performance Disclosure
Net earnings	$ 414	$ 358.8	$ 332.8

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jul. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Insider Trading Policies and Pr

Insider Trading Policies and Procedures	12 Months Ended
	Jul. 31, 2024
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted	true

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jul. 31, 2024
Accounting Policies [Abstract]
Principles of Consolidation	Principles of Consolidation The Consolidated Financial Statements include the accounts of the Company and all its majority-owned subsidiaries. All intercompany accounts and transactions have been elimin ated. The Company’s joint ventures are not majority-owned and are accounted for under the equity meth od. The Company is party to joint ventures with Advanced Filtration Systems Inc. (AFSI) and PT Panata Jaya Mandiri (PTPJM), both of which are considered related parties. The investment and earnings from joint ventures are not material. Certain reclassifications to previously reported financial information on the Consolidated Balance Sheet, Consolidated Statements of Cash Flows and Consolidated Statements of Changes in Stockholders’ Equity have been made to conform to the current period presentation.
Use of Estimates	Use of Estimates The preparation of the Company’s financial statements in conformity with generally accepted accounting principles (GAAP) in the United States (U.S.) requires management to make estimates and assumptions that affect the amount of assets and liabilities and the disclosures regarding contingent assets and liabilities at period end and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
Foreign Currency Translation	Foreign Currency Translation
Cash Equivalents	Cash Equivalents
Revenue Recognition	Revenue Recognition Revenue is measured as the amount of consideration the Company expects to receive in exchange for the fulfillment of performance obligations. The transaction price of a contract could be reduced by variable consideration including volume purchase rebates and discounts, product refunds and returns. At the time of sale to a customer, the Company records an estimate of variable consideration as a reduction from gross sales. The Company primarily relies on historical experience and anticipated future performance to estimate the variable consideration. Revenue is recognized to the extent it is probable a significant reversal of revenue will not occur when the contingency is resolved. The Company accounts for amounts billed to customers for reimbursement of shipping and handling costs by recording these amounts as revenue and accruing costs when the related revenue is recognized. For most customer contracts, the Company recognizes revenue at a point in time when control of the goods or services is transferred to the customer. For product sales, control is typically deemed to have transferred in accordance with the shipping terms, either at the time of shipment from the plants or distribution centers or the time of delivery to the customers. Revenue is recognized for services upon completion o f those services. Payment terms vary by customer and the geographic location of the customer. The Company’s contracts with customers do not include significant financing components or non-cash consideration. The Company has some contracts with customers where the performance obligations are satisfied over time. Certain customer contracts provide the Company with an enforceable right to payment of the transaction price for performance completed to date and the Company uses either an input or an output method of production to measure the progress towards the completion of the performance obligation in these arrangements, depending on the nature of the contract. The timing of revenue recognized from these products is slightly accelerated compared to revenue recognized at the time of shipment or delivery. The Company generally does not incur significant incremental costs related to obtaining or fulfilling a contract prior to the start of a project. The Company may incur certain fulfillment costs such as initial design or mobilization costs which are capitalized if they relate directly to the contract, if they are expected to generate resources that will be used to satisfy the Company’s performance obligation under the contract and if they are expected to be recovered through revenues generated under the contract. Such costs, which are amortized over the life of the respective project, were not material for any period presented. The Company does not pay upfront sales commissions on contracts when the related contract period is greater than one year and thus has not capitalized any amounts as of July 31, 2024 and 2023 , see Note 3.
Shipping and Handling	Shipping and Handling Shipping and handling costs on products sold of $91.5 million , $91.2 million
Accounts Receivable, Net and Allowance for Doubtful Accounts	Accounts Receivable, Net and Allowance for Doubtful Accounts Accounts receivable, net are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of credit losses in its existing accounts receivable. The Company determines the allowance based on utilization of a combination of aging schedules with reserve rates applied to both current and aged receivables using historical write-off experience, regional economic data and evaluation of specific customer accounts for risk of loss and changes in current or projected conditions to calculate the allowances related to accounts receivable, net. The Company reviews its allowance for doubtful accounts monthly. Account balances are reviewed on a pooled basis by reporting unit and geographic region and are reserved when the Company determines it is probable the receivable will not be recovered. The Company reduces the receivable and corresponding allowance when it confirms an account is uncollectible.
Accounts Receivable, Net and Allowance for Doubtful Accounts	Accounts Receivable, Net and Allowance for Doubtful Accounts Accounts receivable, net are recorded at the invoiced amount and do not bear interest. The allowance for doubtful accounts is the Company’s best estimate of the amount of credit losses in its existing accounts receivable. The Company determines the allowance based on utilization of a combination of aging schedules with reserve rates applied to both current and aged receivables using historical write-off experience, regional economic data and evaluation of specific customer accounts for risk of loss and changes in current or projected conditions to calculate the allowances related to accounts receivable, net. The Company reviews its allowance for doubtful accounts monthly. Account balances are reviewed on a pooled basis by reporting unit and geographic region and are reserved when the Company determines it is probable the receivable will not be recovered. The Company reduces the receivable and corresponding allowance when it confirms an account is uncollectible.
Factoring Arrangements	Factoring Arrangements The Company has agreements with financial institutions to sell certain trade receivables from customers without recourse. The Company accounts for trade receivable transfers as sales and de-recognizes the sold receivables from the Consolidated Balance Sheets. During fiscal 2024, the Company sold $29.9 million re ceivables under factoring agreements. Costs incurred on these sales during the year ended July 31, 2024 were $1.7 million and are included in the cost of sales within the Consolidated Statements of Earnings. Cash received from selling receivables of $28.2 million is presented as a change in accounts receivable within the operating section of the Consolidated Statements of Cash Flow.
Inventories	Inventories
Property, Plant and Equipment	Property, Plant and Equipment
Internal-Use Software	Internal-Use Software and Cloud Computing Arrangements The Company capitalizes direct costs of materials and services used in the development and purchase of internal-use software. Amounts capitalized are amortized on a straight-line basis over a period of five The Company capitalizes certain costs incurred during the application development stage of implementation of internal-use software in cloud computing arrangements. Amounts capitalized are amortized on a straight-line basis over a period of five
Cloud Computing Arrangements	Internal-Use Software and Cloud Computing Arrangements The Company capitalizes direct costs of materials and services used in the development and purchase of internal-use software. Amounts capitalized are amortized on a straight-line basis over a period of five The Company capitalizes certain costs incurred during the application development stage of implementation of internal-use software in cloud computing arrangements. Amounts capitalized are amortized on a straight-line basis over a period of five
Goodwill and Intangible Assets	Goodwill and Intangible Assets Goodwill represents the excess of the purchase price over the fair value of net assets acquired in business combinations under the purchase method of accounting. Goodwill is assessed for impairment annually or if an event occurs or circumstances change that would indicate the carrying amount may be impaired. The Company performed its annual impairment assessment during the third quarter of fiscal 2024. The goodwill impairment assessment is conducted at a reporting unit level, which is one level below the operating segment level and utilizes either a qualitative or quantitative assessment. The Company determined the fair value for all its reporting units was substantially in excess of their respective carrying values and there were no indicators of impairment for any of the reporting units evaluated. An impairment loss would be recognized when the carrying amount of a reporting unit’s net assets exceeds the estimated fair value of the reporting unit, see Note 6.
Business Combinations	Business Combinations The Company allocates the purchase price of acquired businesses to the estimated fair values of the assets acquired and liabilities assumed, as well as any contingent consideration, where applicable, as of the date of acquisition. The fair values of the long-lived assets acquired, primarily intangible assets, are determined using calculations which can be complex and require significant judgment. Estimates include many factors such as the nature of the acquired company’s business, its historical financial position and results, technology obsolescence, customer retention rates, discount rates, royalty rates and expected future performance. Independent valuation specialists are used to assist in determining certain fair value calculations. During the measurement period, which may be up to one year from the acquisition date, the Company may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Any adjustments required after the measurement period are recorded in the Consolidated Statements of Earnings.
Recoverability of Long-Lived Assets	Recoverability of Long-Lived Assets
Income Taxes	Income Taxes The provision for income taxes is computed based on the pretax income reported for financial statement purposes. Deferred tax assets and liabilities are recognized for the expected future tax consequences attributed to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities are measured using the enacted tax rates expected to apply to taxable income in the years in which those temporary differences are anticipated to reverse. Valuation allowances are recorded to reduce deferred tax assets when it is more likely than not a tax benefit will not be realized.
Leases	Leases The Company determines whether an arrangement that provides control over the use of an asset to the Company is a lease. The Company recognizes a lease liability and corresponding right-of-use asset on the Consolidated Balance Sheets based on the present value of future lease payments and recognizes lease expense on a straight-line basis over the lease term. Operating lease assets and liabilities are recognized at the commencement date based on the present value of lease payments over the lease term (or at fair values in the case of those leases assumed in an acquisition). Leases with an initial term of 12 months or less are not recorded on the Consolidated Balance Sheets and are expensed on a straight-line basis over the lease term. Variable lease expense is immaterial and primarily includes leases with payments indexed to inflation when the index changes after lease commencement. The Company has elected to separate payments fo
Stock-Based Compensation	Stock-Based Compensation
Treasury Stock	Treasury Stock Repurchased common stock is stated at cost, determined on an average cost basis and is presented as a reduction of stockholders’ equity on the Consolidated Balance Sheets.
Research and Development Expenses	Research and Development Expenses
Foreign Currency Forward Contracts - Cash Flow Hedges and Derivatives not Designated as Hedging Instruments	Foreign Currency Forward Contracts - Cash Flow Hedges and Derivatives Not Designated as Hedging Instruments The Company buys materials from foreign suppliers. Those transactions can be denominated in those suppliers’ local currency. The Company also sells to customers in foreign countries. Those transactions can be denominated in those customers’ local currency. Both of these transaction types can create volatility in the Company’s financial statements. The Company uses foreign currency forward contracts to manage those exposures and fluctuations. These contracts generally mature in 12 months or less, which is consistent with the forecasts of the rel ated purchases and sales. Certain contracts are designated as cash flow hedges, whereas the remaining contracts, most of which are related to certain intercompany transactions which offset balance sheet exposure, are not designated as hedging instruments, see Notes 12, 15 and 16. Net Investment Hedges The Company uses fixed-to-fixed cross-currency swap agreements to hedge its exposure to adverse foreign currency exchange rate movements for its operations in Europe. The Company has elected the spot method for designating these contracts as net investment hedges. The maturity dates range from 2027 to 2029, see Notes 12, 15 and 16. Interest Rate Swaps - Cash Flow Hedges The Company uses swap agreements to hedge exposure related to interest expense and to manage its exposure to interest rate movements. The Company enters into interest rate s wap agreements designated as cash flow hedges to hedge future fixed-rate debt issuances, which effectively fix a portion of interest payments.
Product Warranties	Product Warranties
New Significant Accounting Standards Recently Adopted and Not Yet Adopted	New Significant Accounting Standards Recently Adopted There were no new significant accounting standards adopted in fiscal 2024 or 2023 that had a material impact on the Company’s financial statements. New Significant Accounting Standards Not Yet Adopted The Company considers the applicability and impact of the FASB’s ASUs issued but not yet adopted. In December 2023, FASB issued ASU No. 2023-09, Income Taxes (Topic 820), “Improvements to Income Tax Disclosures,” which enhances the transparency and decision usefulness of income tax disclosures. The guidance is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. The Company does not expect adoption of this standard will have a material impact on the related disclosures within its financial statements. In November 2023, FASB issued ASU No. 2023-07, Segment Reporting (Topic 280), “Improvements to Reportable Segment Disclosures,” which improves the segment disclosures to include reportable segment’s expenses. The guidance is effective for fiscal years beginning after December 15, 2023, with early adoption permitted. This ASU is applicable to annual reporting for the Company’s fiscal 2025 and interim reporting for the first quarter of the Company’s fiscal 2026. The Company does not expect adoption of this standard will have a material impact on the related disclosures within its financial statements. In October 2023, FASB issued ASU No. 2023-06, "Disclosure Improvements: Codification Amendments in Response to the SEC's Disclosure Update and Simplification Initiative," which modifies the disclosure or presentation requirements of various FASB topics in the Codification. The effective date for each amendment will be the date on which the SEC's removal of that related disclosure from Regulation S-K becomes effective, with early adoption prohibited. The Company is in the process of evaluating the impact of the ASU on its related disclosures. In June 2022, the FASB issued ASU 2022-03, Fair Value Measurement (Topic 820), “ Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions,” which clarifies that a contractual restriction on the sale of an equity security is not considered part of the unit of account of the equity security and, therefore, is not considered in measuring fair values; it also requires additional disclosures, including the nature and remaining duration of such restrictions. The guidance is effective for fiscal years beginning after December 15, 2023, with early application permitted. This ASU is applicable to the Company’s fiscal year beginning in the first quarter of fiscal 2025. The Company does not expect adoption of this standard will have a material impact on its financial statements.
Earnings Per Share	Basic net earnings per share (EPS) is computed by dividing net earnings by the weighted average number of outstanding common shares. Diluted net EPS is computed by dividing net earnings by the weighted average number of outstanding common shares and common share equivalents relating to stock options and other stock incentive plans.

Acquisitions and Equity Metho_2

Acquisitions and Equity Method Investments (Tables)	12 Months Ended
	Jul. 31, 2024
Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract]
Schedule of Components of Acquisitions, Net of Cash Acquired	The components of the UTEC and Isolere acquisitions, net of cash acquired, as of the acquisition date were as follows (in millions): 2023 Intangible assets: Technology $ 84.9 Trademarks and tradenames 8.2 Customer relationships 1.2 Non-competition agreements 2.7 Intangible assets acquired 97.0 Tangible assets, net 10.4 Assets acquired, net 107.4 Goodwill 124.0 Aggregate purchase price 231.4 Add deferred tax asset 7.0 Less deferred tax liability (24.0) Less cash acquired (4.8) Acquisitions, net of cash acquired $ 209.6

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Jul. 31, 2024
Revenue from Contract with Customer [Abstract]
Schedule of Disaggregation of Revenue	Net sales, generally disaggregated by location where the customer’s order was placed, were as follows (in millions): Year Ended July 31, 2024 2023 2022 U.S. and Canada $ 1,583.1 $ 1,464.7 $ 1,336.8 Europe, Middle East and Africa (EMEA) 1,012.9 1,007.8 963.6 Asia Pacific (APAC) 601.5 608.8 669.0 Latin America (LATAM) 388.8 349.5 337.2 Total net sales $ 3,586.3 $ 3,430.8 $ 3,306.6

Inventories, Net (Tables)

Inventories, Net (Tables)	12 Months Ended
	Jul. 31, 2024
Inventory Disclosure [Abstract]
Schedule of Components of Inventory	The components of inventories, net were as follows (in millions): July 31, 2024 2023 Raw materials $ 177.4 $ 155.1 Work in process 61.2 50.9 Finished products 238.1 212.1 Total inventories, net $ 476.7 $ 418.1

Property, Plant and Equipment_2

Property, Plant and Equipment, Net (Tables)	12 Months Ended
	Jul. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Components of Property, Plant And Equipment	The components of property, plant and equipment, net were as follows (in millions): July 31, 2024 2023 Land $ 29.5 $ 29.3 Buildings 451.9 430.8 Machinery and equipment 1,052.1 989.0 Computer software 134.7 142.0 Construction in progress 68.4 107.7 Less accumulated depreciation (1,091.1) (1,045.9) Total property, plant and equipment, net $ 645.5 $ 652.9

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	12 Months Ended
	Jul. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Reconciliation of Goodwill	Goodwill by reportable segment was as follows (in millions): Mobile Industrial Life Sciences Segment Total Balance as of July 31, 2022 $ 25.3 $ 282.1 $ 38.4 $ 345.8 Goodwill acquired — — 125.1 125.1 Foreign exchange translation 0.2 7.0 3.0 10.2 Balance as of July 31, 2023 $ 25.5 $ 289.1 $ 166.5 $ 481.1 Goodwill acquired — 1.9 — 1.9 Purchase price adjustments — — (1.1) (1.1) Foreign exchange translation (0.1) (1.1) (2.3) (3.5) Balance as of July 31, 2024 $ 25.4 $ 289.9 $ 163.1 $ 478.4
Schedule of Reconciliation of Intangibles	Intangible asset classes were as follows (in millions): Year Ended July 31, 2024 Weighted Amortizable Life (in Years) Gross Carrying Amount Accumulated Amortization Net Customer relationships 9.4 $ 77.4 $ (39.9) $ 37.5 Trademarks 8.1 14.2 (3.8) 10.4 Technology and patents 16.7 142.4 (20.4) 122.0 Non-compete agreements 2.7 3.9 (1.9) 2.0 Total intangible assets $ 237.9 $ (66.0) $ 171.9 Year Ended July 31, 2023 Weighted Amortizable Life (in Years) Gross Carrying Amount Accumulated Amortization Net Customer relationships 10.8 $ 107.8 $ (65.6) $ 42.2 Trademarks 9.0 15.9 (3.9) 12.0 Technology and patents 17.6 149.7 (19.2) 130.5 Non-compete agreements 3.1 4.0 (0.6) 3.4 Total intangible assets $ 277.4 $ (89.3) $ 188.1
Schedule of Expected Amortization Expense	Amortization expense relating to existing intangible assets as of July 31, 2024 was as follows (in millions): 2025 $ 15.3 2026 14.1 2027 13.7 2028 13.2 2029 12.1 Thereafter 103.5 Total amortization expense $ 171.9

Short-Term Borrowings and Lon_2

Short-Term Borrowings and Long-Term Debt (Tables)	12 Months Ended
	Jul. 31, 2024
Debt Disclosure [Abstract]
Schedule of Short-term Borrowings	Short-term borrowings were as follows (in millions): European Commercial Paper Program U.S. Credit Facilities European Operations Credit Facilities Rest of the World Credit Facilities Total Year Ended July 31, 2024 2023 2024 2023 2024 2023 2024 2023 2024 2023 Available credit facilities $ 108.3 $ 110.3 $ 100.0 $ 100.0 $ 48.4 $ 45.0 $ 46.7 $ 50.8 $ 303.4 $ 306.1 Reductions to borrowing capacity: Outstanding borrowings 22.8 24.3 0.2 9.8 — — 5.3 — 28.3 34.1 Other non-borrowing reductions — — — — 38.9 28.8 25.7 18.8 64.6 47.6 Total reductions 22.8 24.3 0.2 9.8 38.9 28.8 31.0 18.8 92.9 81.7 Remaining borrowing capacity $ 85.5 $ 86.0 $ 99.8 $ 90.2 $ 9.5 $ 16.2 $ 15.7 $ 32.0 $ 210.5 $ 224.4 Weighted average interest rate as of July 31, 2024 and 2023 4.34 % 4.09 % 6.44 % 6.17 % N/A N/A 0.56 % N/A 3.62 % 4.69 %
Schedule of Long-term Debt	Long-term debt was as follows: Interest Rate Outstanding Balance Financial Instrument Fixed or Variable Amount Maturity Date July 31, 2024 July 31, 2023 July 31, 2024 July 31, 2023 Unsecured senior notes Fixed $125.0 million March 27, 2024 3.72 % 3.72 % $ — $ 125.0 Unsecured senior notes Fixed $125.0 million June 17, 2030 3.18 % 3.18 % 125.0 125.0 Unsecured senior notes Fixed $100.0 million August 5, 2031 2.50 % 2.50 % 100.0 100.0 Unsecured revolving credit facility Variable $500.0 million May 21, 2026 6.44 % 5.09 % 110.0 96.2 Unsecured term loan Variable €80.0 million March 26, 2029 4.69 % 4.41 % 86.6 88.2 Unsecured senior notes Fixed $50.0 million November 5, 2028 2.12 % 2.12 % 50.0 50.0 Unsecured senior notes Fixed $25.0 million April 16, 2025 2.93 % 2.93 % 25.0 25.0 Unsecured term loan Variable ¥1.0 billion July 31, 2028 0.76 % 0.57 % 6.7 7.0 Unsecured term loan Variable ¥1.0 billion July 15, 2026 0.68 % 0.49 % 6.7 7.0 Debt issuance costs, net (1.6) (1.8) Subtotal 508.4 621.6 Less current maturities (25.0) (125.0) Total long-term debt $ 483.4 $ 496.6
Schedule of Maturities of Long-term Debt	Future maturities of the Company’s long-term debt as of July 31, 2024 were as follows (in millions): 2025 $ 25.0 2026 116.7 2027 — 2028 6.7 2029 136.6 Thereafter 225.0 Total future maturities payments 510.0 Less debt issuance costs, net (1.6) Total future maturities payments, net of debt issuance costs $ 508.4

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jul. 31, 2024
Income Tax Disclosure [Abstract]
Schedule of Components of Earnings Before Income Taxes	The components of earnings before income taxes were as follows (in millions): Year Ended July 31, 2024 2023 2022 U.S. $ 233.4 $ 178.0 $ 132.8 Foreign 301.9 290.7 305.6 Total $ 535.3 $ 468.7 $ 438.4
Schedule of Components of the Provision For Income Taxes	The components of the provision for income taxes were as follows (in millions): Year Ended July 31, 2024 2023 2022 Current Federal $ 47.2 $ 38.1 $ 17.4 State 8.8 7.3 4.9 Foreign 89.6 79.8 84.7 Total current 145.6 125.2 107.0 Deferred Federal (16.1) (13.3) 2.8 State (1.7) (1.8) (0.3) Foreign (6.5) (0.2) (3.9) Total deferred (24.3) (15.3) (1.4) Total provision for income taxes $ 121.3 $ 109.9 $ 105.6
Schedule of Reconciliation of the U.S. Statutory Income Tax Rate with the Effective Income Tax Rate	The reconciliation of the U.S. statutory federal income tax rate with the effective income tax rate was as follows: Year Ended July 31, 2024 2023 2022 U.S. statutory federal income tax rate 21.0 % 21.0 % 21.0 % State income taxes 1.2 0.9 0.9 Foreign operations 2.7 3.8 3.6 Global Intangible Low Tax Income 0.2 0.2 0.3 Foreign Derived Intangible Income (1.3) (1.6) (0.6) Research and development credit (0.9) (0.7) (0.6) Change in unrecognized tax benefits 1.2 — (0.8) Tax benefits on stock-based compensation (1.2) (0.7) (0.5) Other (0.2) 0.5 0.8 Effective income tax rate 22.7 % 23.4 % 24.1 %
Schedule of the Tax Effects of Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities	The tax effects of temporary differences that give rise to deferred tax assets and liabilities were as follows (in millions): July 31, 2024 2023 Deferred tax assets Accrued expenses $ 14.3 $ 12.2 Compensation and retirement plans 26.6 24.7 Capitalization of R&D costs 32.9 17.6 Net operating loss (NOL) and tax credit carryforwards 17.6 15.1 Operating lease assets 15.6 15.0 Other 6.2 6.2 Gross deferred tax assets 113.2 90.8 Valuation allowance (9.1) (6.4) Deferred tax assets, net of valuation allowance 104.1 84.4 Deferred tax liabilities Depreciation and amortization (74.5) (79.5) Operating lease liabilities (14.9) (15.1) Other (3.8) (4.2) Deferred tax liabilities (93.2) (98.8) Net deferred tax asset (liability) $ 10.9 $ (14.4)
Schedule of NOL and Tax Credit Valuation Allowances	The activity in the NOL and tax credit valuation allowances was as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ (6.4) $ (3.4) $ (4.6) Additions charged to costs and expenses (3.6) (3.0) (0.9) Deductions from reserves 0.9 — 2.1 Balance as of end of year $ (9.1) $ (6.4) $ (3.4)
Schedule of Reconciliation of the Beginning and Ending Amount of Gross Unrecognized Tax Benefits	The reconciliation of the beginning and ending amount of gross unrecognized tax benefits was as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ 15.0 $ 15.2 $ 18.7 Additions for tax positions of the current year 2.8 2.5 2.7 Additions for tax positions of prior years 6.2 — — Reductions for tax positions of prior years (0.1) 0.1 (1.1) Reductions due to lapse of applicable statute of limitations (3.1) (2.8) (5.1) Balance as of end of year $ 20.8 $ 15.0 $ 15.2

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jul. 31, 2024
Leases [Abstract]
Schedule of Lease Cost	The Company’s operating lease costs were as follows (in millions): Year Ended July 31, 2024 2023 Operating lease cost $ 29.5 $ 24.5 Short-term lease cost 3.0 3.2 Total lease costs $ 32.5 $ 27.7
Schedule of Supplemental Balance Sheet Information	Supplemental balance sheet information for the Company was as follows (in millions): July 31, Balance Sheet Location 2024 2023 Right-of-use lease assets Other long-term assets $ 59.7 $ 59.4 Current lease liabilities Other current liabilities $ 20.2 $ 17.8 Long-term lease liabilities Other long-term liabilities $ 41.3 $ 42.4 Additional information related to operating leases was as follows: July 31, 2024 2023 Weighted average remaining lease term (years) 3.5 4.2 Weighted average discount rate 4.61 % 3.89 %
Schedule of Operating Lease Liability	Remaining payments for operating leases having initial terms of more than one year as of July 31, 2024 were as follows (in millions): 2025 $ 23.0 2026 18.5 2027 12.2 2028 6.9 2029 4.6 Thereafter 2.4 Total future lease payments 67.6 Less imputed interest 6.1 Present value of future lease payments $ 61.5

Earnings Per Share (Tables)

Earnings Per Share (Tables)	12 Months Ended
	Jul. 31, 2024
Earnings Per Share [Abstract]
Schedule of Information Necessary to Calculate Basic and Diluted Earnings Per Share	Basic and diluted net EPS calculations were as follows (in millions, except per share amounts): Year Ended July 31, 2024 2023 2022 Net earnings $ 414.0 $ 358.8 $ 332.8 Weighted average common shares outstanding Weighted average common shares – basic 120.7 121.8 123.7 Dilutive impact of stock-based awards 1.9 1.8 1.5 Weighted average common shares – diluted 122.6 123.6 125.2 Net EPS – basic $ 3.43 $ 2.95 $ 2.69 Net EPS – diluted $ 3.38 $ 2.90 $ 2.66 Stock options excluded from net EPS calculation 0.0 0.0 1.6

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	12 Months Ended
	Jul. 31, 2024
Stockholders' Equity Note [Abstract]
Schedule of Treasury Stock Activity	Treasury stock share activity was as follows: Year Ended July 31, 2024 2023 Balance as of beginning of year 30,528,696 29,089,612 Stock repurchases 2,465,000 2,485,000 Net issuance upon exercise of stock options (1,294,475) (941,837) Issuance under compensation plans (149,329) (84,942) Other activity (16,700) (19,137) Balance as of end of year 31,533,192 30,528,696

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	12 Months Ended
	Jul. 31, 2024
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Loss By Component	Changes in accumulated other comprehensive loss for the years ended July 31, 2024 and 2023 were as follows (in millions): Foreign Pension Derivative Total Balance as of July 31, 2023, net of tax $ (109.6) $ (67.2) $ 4.3 $ (172.5) Other comprehensive loss before reclassifications and tax (24.2) (9.0) (1) (0.8) (34.0) Tax benefit — 2.3 0.2 2.5 Other comprehensive loss before reclassifications, net of tax (24.2) (6.7) (0.6) (31.5) Reclassifications, before tax — 6.3 (2) 0.3 6.6 Tax expense — (1.5) — (1.5) Reclassifications, net of tax — 4.8 0.3 (3) 5.1 Other comprehensive loss, net of tax (24.2) (1.9) (0.3) (26.4) Balance as of July 31, 2024, net of tax $ (133.8) $ (69.1) $ 4.0 $ (198.9) Balance as of July 31, 2022, net of tax $ (143.6) $ (67.5) $ 5.5 $ (205.6) Other comprehensive income (loss) before reclassifications and tax 34.0 (6.9) (1) (1.9) 25.2 Tax benefit — 2.2 0.5 2.7 Other comprehensive income (loss) before reclassifications, net of tax 34.0 (4.7) (1.4) 27.9 Reclassifications, before tax — 7.5 (2) 0.3 7.8 Tax expense — (2.5) (0.1) (2.6) Reclassifications, net of tax — 5.0 0.2 (3) 5.2 Other comprehensive income (loss), net of tax 34.0 0.3 (1.2) 33.1 Balance as of July 31, 2023, net of tax $ (109.6) $ (67.2) $ 4.3 $ (172.5) (1) In fiscal 2024 and 2023, pension settlement accounting was triggered. In addition, pension curtailment accounting was triggered in fiscal 2024 and 2023. Remeasurements of the Company’s pension obligations resulted in an increase of $9.0 million and $6.9 million in fiscal 2024 and 2023, respectively, to accumulated other comprehensive loss on the Consolidated Balance Sheets, see Note 14. (2) Amounts include reclassifications of $4.8 million and $6.6 million, a foreign currency translation loss of $0.1 million and gain of $1.4 million and net amortization of prior service costs and actuarial losses of $1.4 million and $2.3 million in fiscal 2024 and 2023, respectively. Amounts are included in other income, net in the Consolidated Statements of Earnings, see Note 14. (3) Relates to designated foreign currency forward contracts that were reclassified from accumulated other comprehensive loss on the Consolidated Balance Sheets to net sales, cost of sales and operating expenses in the Consolidated Statements of Earnings, see Note 15.

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Jul. 31, 2024
Share-Based Payment Arrangement, Noncash Expense [Abstract]
Schedule of Valuation Assumption Used to Determine Fair Value of Stock-Based Compensation Awards	The fair value of these awards was determined using the following inputs: Year Ended July 31, 2024 2023 2022 Risk-free interest rate 3.8% - 4.6% 3.8% - 4.2% 1.2% - 1.8% Expected volatility 26.8% - 27.2% 26.8% - 27.5% 26.0% - 27.0% Expected dividend yield 1.6 % 1.6 % 1.6 % Expected life: Director grants 8 years 8 years 8 years Officer grants 7 years 7 years 7 years Non-officer grants 7 years 7 years 7 years
Schedule of Stock Option Activity	Option activity was as follows: Options Weighted Balance outstanding as of July 31, 2023 6,777,407 $ 47.80 Granted 809,278 59.95 Exercised (1,372,191) 42.30 Expired/forfeited (51,438) 54.14 Balance outstanding as of July 31, 2024 6,163,056 $ 50.57
Schedule of Outstanding and Exercisable Options	Outstanding and exercisable stock options as of July 31, 2024 were as follows: Range of Exercise Prices Number Weighted Weighted Number Weighted Weighted $28.00 to $37.99 494,960 1.3 $ 29.54 494,960 1.3 $ 29.54 $38.00 to $43.99 620,682 2.3 42.25 620,682 2.3 42.25 $44.00 to $49.99 1,255,623 4.9 45.97 1,255,623 4.9 45.97 $50.00 to $55.99 1,538,333 6.8 51.33 977,432 6.0 51.58 $56.00 and above 2,253,458 7.0 59.52 1,156,389 5.5 59.23 6,163,056 5.6 $ 50.57 4,505,086 4.5 $ 48.27
Schedule of Status of Options that Contain Vesting Provisions	For the year ended July 31, 2024, activity for non-vested stock options that contain vesting provisions was as follows: Options Weighted Balance outstanding as of beginning of year 1,783,711 $ 14.27 Granted 809,278 19.00 Vested (893,885) 13.34 Forfeited (41,134) 16.61 Balance outstanding as of end of year 1,657,970 $ 17.02
Schedule of Performance Shares Activity	The weighted average grant date fair value related to the Company’s performance-based awards was as follows: Year Ended July 31, 2024 2023 2022 Weighted average grant date fair value $ 59.66 $ 50.89 $ 59.40 Performance-based awards for non-vested activity were as follows: Performance Shares Weighted Balance outstanding as of July 31, 2023 194,761 $ 54.46 Granted 114,800 59.66 Vested (81,661) 59.40 Forfeited — — Balance outstanding as of July 31, 2024 227,900 $ 55.31

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Jul. 31, 2024
Defined Benefit Plan Disclosure
Schedule of Net Periodic Pension Costs and Amounts Recognized in Other Comprehensive Income	Net periodic pension costs for the Company’s pension plans were as follows (in millions): Year Ended July 31, 2024 2023 2022 Net periodic pension costs Service cost $ 5.2 $ 6.7 $ 6.9 Interest cost 20.4 17.0 10.6 Expected return on assets (25.7) (25.3) (24.8) Prior service cost amortization 0.1 — 0.2 Actuarial loss amortization 1.5 2.1 6.9 Settlement loss 4.9 5.5 3.0 Curtailment loss 0.2 0.2 — Net periodic pension costs 6.6 6.2 2.8 Other changes recognized in other comprehensive (loss) income: Prior service cost 0.1 (0.4) — Net actuarial (loss) gain (9.1) (5.9) (1.3) Amortization of prior service cost 0.3 0.2 0.3 Amortization of net actuarial loss 6.4 7.7 9.9 Total recognized in other comprehensive (loss) income (2.3) 1.6 8.9 Total recognized in net periodic pension costs and other comprehensive (loss) income $ (8.9) $ (4.6) $ 6.1
Schedule of Changes in Projected Benefit Obligations, Fair Value of Plan Assets and Funded Status	The changes in projected benefit obligations, fair value of plan assets and funded status of the Company’s pension plans for the years ended July 31, 2024 and 2023 were as follows (in millions): Year Ended July 31, 2024 2023 Change in projected benefit obligation Projected benefit obligation, beginning of year $ 401.1 $ 442.6 Service cost 5.2 6.7 Interest cost 20.4 17.0 Plan amendments (0.1) 0.2 Participant contributions 0.8 0.7 Actuarial (gain) loss 11.7 (42.0) Foreign currency exchange rates (1.8) 9.2 Settlements paid (15.6) (17.0) Acquisition 0.6 1.2 Benefits paid (18.6) (17.5) Projected benefit obligation, end of year 403.7 401.1 Change in fair value of plan assets Fair value of plan assets, beginning of year 416.0 459.8 Actual return on plan assets 28.4 (22.1) Company contributions 2.8 2.6 Participant contributions 0.8 0.7 Foreign currency exchange rates (1.1) 8.3 Settlements paid (15.6) (17.0) Acquisition 0.6 1.2 Benefits paid (18.6) (17.5) Fair value of plan assets, end of year 413.3 416.0 Funded status of plans, end of year $ 9.6 $ 14.9 Amounts recognized on the Consolidated Balance Sheets Other long-term assets $ 35.8 $ 34.7 Other current liabilities (1.5) (1.7) Other long-term liabilities (24.7) (18.1) Net recognized asset $ 9.6 $ 14.9
Schedule of Weighted-Average Discount Rates in Determining Actuarial Present Value of Projected Benefit Obligation	The significant assumptions used in determining the actuarial present value of the projected benefit obligation were as follows: Year Ended July 31, 2024 2023 U.S. plans Discount rate 5.44 % 5.58 % Rate of compensation increase N/A N/A Non-U.S. plans Discount rate 4.33 % 4.80 % Rate of compensation increase 3.05 % 3.12 %
Schedule of Assumptions Used to Determine Net Periodic Benefit Cost	The weighted average discount rates, expected returns on plan assets and rates of increase in future compensation levels used to determine the net periodic pension costs were as follows: Year Ended July 31, 2024 2023 2022 U.S. plans Discount rate 5.58 % 4.62 % 2.55 % Expected rate of return on plan assets 6.16 % 5.66 % 5.41 % Rate of compensation increase N/A N/A N/A Non-U.S. plans Discount rate 4.80 % 3.26 % 1.60 % Expected rate of return on plan assets 5.01 % 4.39 % 3.40 % Rate of compensation increase 3.05 % 3.12 % 2.99 %
Schedule of Estimated Fair Value of Pension Plan Assets and their Respective Levels in the Fair Value Hierarchy	During the year ended July 31, 2024, the Company’s asset allocation was as follows: Salaried Pension Plan Hourly Pension Plan Global equity securities 33 % 32 % Fixed income securities 65 67 Real asset funds 1 — Cash and cash equivalents 1 1 Total 100 % 100 %
Schedule of Certain Investments at NAV	Certain investments, valued at NAV, had the following unfunded commitments and/or redemption restrictions (in millions): July 31, 2024 July 31, 2023 NAV Unfunded Commitments NAV Unfunded Commitments Redemption Frequency Redemption Notice (Days) Global equity securities $ 31.1 $ 1.8 $ 33.6 $ 1.8 Daily 0 - 5 Fixed income securities 10.2 — 9.5 — Daily, Weekly and Quarterly 0 - 60 Real asset funds 2.9 4.2 3.1 4.2 Not eligible N/A Total U.S. assets $ 44.2 $ 6.0 $ 46.2 $ 6.0
Schedule of Estimated Future Benefit Payments	Estimated future benefit required payments for the Company’s pension plans as of July 31, 2024 were as follows (in millions): 2025 $ 27.8 2026 $ 27.6 2027 $ 28.6 2028 $ 28.0 2029 $ 31.7 2030-2034 $ 158.7
U.S. Plan
Defined Benefit Plan Disclosure
Schedule of Estimated Fair Value of Pension Plan Assets and their Respective Levels in the Fair Value Hierarchy	The estimated fair value of pension plan assets and their respective levels in the fair value hierarchy by asset category were as follows (in millions): Level 1 Level 2 Level 3 Total Balances as of July 31, 2024 Cash and cash equivalents $ 2.4 $ 0.5 $ — $ 2.9 Global equity securities 58.2 54.5 — 112.7 Fixed income securities 80.4 128.0 — 208.4 Insurance contracts — — 42.7 42.7 Total investments in the fair value hierarchy $ 141.0 $ 183.0 $ 42.7 366.7 Investments using NAV as practical expedient 44.2 Total investment, at fair value 410.9 Accrued income 2.4 Total assets $ 413.3 Balances as of July 31, 2023 Cash and cash equivalents $ 3.6 $ 0.7 $ — $ 4.3 Global equity securities 61.2 55.7 — 116.9 Fixed income securities 90.1 117.2 — 207.3 Insurance contracts — — 41.3 41.3 Total investments in the fair value hierarchy $ 154.9 $ 173.6 $ 41.3 369.8 Investments using NAV as practical expedient 46.2 Total investment, at fair value $ 416.0
Non - U.S. Plan
Defined Benefit Plan Disclosure
Schedule of the Changes in the Fair Value of Non-U.S. Pension Plans' Assets with Unobservable Inputs	The changes in the fair values of the pension plans’ Level 3 assets were as follows (in millions): Year Ended July 31, 2024 2023 2022 Balance as of beginning of year $ 41.3 $ 35.4 $ 37.7 Unrealized gains 3.4 2.7 3.5 Foreign currency exchange (0.8) 3.0 (5.6) Purchases and sales, net (1.2) 0.2 (0.2) Balance as of end of year $ 42.7 $ 41.3 $ 35.4

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Jul. 31, 2024
Fair Value Disclosures [Abstract]
Schedule of Derivatives on Balance Sheet	The fair value of the Company’s derivative contracts, recorded on the Consolidated Balance Sheets, was as follows (in millions): Assets Liabilities July 31, July 31, Balance Sheet Location 2024 2023 2024 2023 Designated as hedging instruments Foreign currency forward contracts Other current assets, other current liabilities $ 0.1 $ 0.6 $ — $ 0.1 Net investment hedges Other current assets, other long-term assets 3.7 3.6 — — Total designated 3.8 4.2 — 0.1 Not designated as hedging instruments Foreign currency forward contracts Other current assets, other current liabilities 1.0 0.7 0.3 1.4 Total not designated 1.0 0.7 0.3 1.4 Total $ 4.8 $ 4.9 $ 0.3 $ 1.5
Schedule of Company’s Contingent Consideration Obligations	A reconciliation of the fair value of the Company’s contingent consideration liability that use unobservable inputs was as follows (in millions): Balance as of July 31, 2023 $ 25.0 Issuances 1.0 Settlements (2.0) Adjustments to fair value (2.2) Balance as of July 31, 2024 $ 21.8 Maximum potential payout $ 29.7 Balance as of July 31, 2022 $ 24.7 Issuances — Adjustments to fair value 0.3 Balance as of July 31, 2023 $ 25.0 Maximum potential payout $ 30.7

Guarantees (Tables)

Guarantees (Tables)	12 Months Ended
	Jul. 31, 2024
Product Warranties Disclosures [Abstract]
Schedule of Guarantor obligations	The outstanding debt contingent liability for standby letters of credit was as follows (in millions): Year Ended July 31, 2024 2023 Contingent liability for standby letters of credit issued under the Company’s revolving credit facility $ 7.5 $ 7.5 Amounts drawn for letters of credit under the Company’s revolving credit facility $ — $ —

Segment Reporting (Tables)

Segment Reporting (Tables)	12 Months Ended
	Jul. 31, 2024
Segment Reporting, Measurement Disclosures [Abstract]
Schedule of Segment Details	Segment details were as follows (in millions): Mobile Solutions Segment Industrial Solutions Segment Life Sciences Segment Corporate and Total Year ended July 31, 2024 Net sales $ 2,250.8 $ 1,066.5 $ 269.0 $ — $ 3,586.3 Equity earnings in unconsolidated affiliates $ 7.3 $ 0.1 $ — $ — $ 7.4 Earnings (loss) before income taxes $ 404.5 $ 198.8 $ (10.4) $ (57.6) $ 535.3 Assets $ 1,339.5 $ 821.7 $ 512.1 $ 241.0 $ 2,914.3 Equity investments in unconsolidated affiliates $ 26.8 $ 0.1 $ — $ — $ 26.9 Year ended July 31, 2023 Net sales $ 2,174.8 $ 1,014.7 $ 241.3 $ — $ 3,430.8 Equity earnings in unconsolidated affiliates $ 3.6 $ — $ — $ — $ 3.6 Earnings (loss) before income taxes $ 330.4 $ 186.2 $ 9.9 $ (57.8) $ 468.7 Assets $ 1,243.8 $ 788.1 $ 513.8 $ 224.8 $ 2,770.5 Equity investments in unconsolidated affiliates $ 24.2 $ 0.2 $ — $ — $ 24.4 Year ended July 31, 2022 Net sales $ 2,126.5 $ 901.0 $ 279.1 $ — $ 3,306.6 Equity earnings in unconsolidated affiliates $ 1.7 $ — $ — $ — $ 1.7 Earnings (loss) before income taxes $ 293.8 $ 133.0 $ 64.9 $ (53.3) $ 438.4 Assets $ 1,319.4 $ 816.0 $ 267.8 $ 197.1 $ 2,600.3 Equity investments in unconsolidated affiliates $ 22.3 $ 0.1 $ — $ — $ 22.4
Schedule of Reconciliation of Net Sales by Product Group Per Segment	Net sales by business unit were as follows (in millions): Year Ended July 31, 2024 2023 2022 Mobile Solutions segment Off-Road $ 380.8 $ 428.7 $ 390.5 On-Road 139.8 145.8 136.1 Aftermarket 1,730.2 1,600.3 1,599.9 Total Mobile Solutions segment 2,250.8 2,174.8 2,126.5 Industrial Solutions segment Industrial Filtration Solutions 901.1 872.2 780.5 Aerospace and Defense 165.4 142.5 120.5 Total Industrial Solutions segment 1,066.5 1,014.7 901.0 Life Sciences segment Total Life Sciences segment 269.0 241.3 279.1 Total Company $ 3,586.3 $ 3,430.8 $ 3,306.6
Schedule of Net Sales by Origination and Property, Plant and Equipment by Geographic Region	Net sales, generally disaggregated by location where the customer’s order was received and property, plant and equipment, net by geographic region were as follows (in millions): Net Sales Property, Plant and Equipment, Net Year ended July 31, 2024 U.S. and Canada $ 1,583.1 $ 209.7 EMEA 1,012.9 199.6 APAC 601.5 75.5 LATAM 388.8 160.7 Total $ 3,586.3 $ 645.5 Year ended July 31, 2023 U.S. and Canada $ 1,464.7 $ 219.7 EMEA 1,007.8 202.4 APAC 608.8 76.5 LATAM 349.5 154.3 Total $ 3,430.8 $ 652.9 Year ended July 31, 2022 U.S. and Canada $ 1,336.8 $ 218.1 EMEA 963.6 184.3 APAC 669.0 59.5 LATAM 337.2 132.5 Total $ 3,306.6 $ 594.4

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Details) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative
Foreign currency transaction losses	$ 1,700,000	$ 6,400,000	$ 6,300,000
Cost of sales	2,311,900,000	$ 2,270,200,000	2,239,200,000
Accounts receivable, sale	29,900,000
Loss on sales of receivables	1,700,000
Proceeds from sale of other receivables	$ 28,200,000
LIFO inventory (as a percent)	35.30%	29.70%
Excess of FIFO over LIFO inventory	$ 51,300,000	$ 56,100,000
Depreciation	82,800,000	80,900,000	85,100,000
Asset impairment charges	$ 0	$ 0	0
Customer relationships
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	9 years 4 months 24 days	10 years 9 months 18 days
Patents and technology
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	16 years 8 months 12 days	17 years 7 months 6 days
Trademarks
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	8 years 1 month 6 days	9 years
Non-competition agreements
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	2 years 8 months 12 days	3 years 1 month 6 days
Foreign currency forward contracts
Collaborative Arrangement and Arrangement Other than Collaborative
Derivative instrument term (in months)	12 months
Minimum
Collaborative Arrangement and Arrangement Other than Collaborative
Capitalization of direct cost, amortization period (in years)	5 years
Minimum | Customer relationships
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	2 years
Minimum | Patents and technology
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	2 years
Minimum | Trademarks
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	2 years
Minimum | Non-competition agreements
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	2 years
Minimum | Building and Building Improvements
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	10 years
Minimum | Machinery and equipment
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	3 years
Minimum | Computer software
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	5 years
Maximum
Collaborative Arrangement and Arrangement Other than Collaborative
Capitalization of direct cost, amortization period (in years)	10 years
Maximum | Customer relationships
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	22 years
Maximum | Patents and technology
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	22 years
Maximum | Trademarks
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	22 years
Maximum | Non-competition agreements
Collaborative Arrangement and Arrangement Other than Collaborative
Finite lived intangible asset estimated useful life (in years)	22 years
Maximum | Building and Building Improvements
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	40 years
Maximum | Machinery and equipment
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	10 years
Maximum | Computer software
Collaborative Arrangement and Arrangement Other than Collaborative
Property, plant and equipment, useful life (in years)	7 years
Shipping and Handling
Collaborative Arrangement and Arrangement Other than Collaborative
Cost of sales	$ 91,500,000	$ 91,200,000	$ 96,400,000

Acquisitions and Equity Metho_3

Acquisitions and Equity Method Investments (Narrative) (Details) € in Millions, $ in Millions			3 Months Ended						12 Months Ended
	Aug. 09, 2024 USD ($)	Aug. 09, 2024 EUR (€)	Jul. 31, 2023 USD ($)	Jul. 31, 2023 EUR (€)	Apr. 30, 2023 USD ($)	Jul. 31, 2022 USD ($)	Jan. 31, 2022 USD ($)	Jan. 31, 2022 EUR (€)	Jul. 31, 2024 USD ($)	Jul. 31, 2023 USD ($)	Jul. 31, 2022 USD ($)
Business Acquisition
Acquisitions, net of cash acquired									$ 2	$ 209.2	$ 68.9
Goodwill			$ 481.1			$ 345.8			$ 478.4	481.1	345.8
Medica S.p.A | Subsequent Event
Business Acquisition
Remaining equity interest (as a percent)	51%	51%
Additional ownership acquisition, term (in years)	4 years	4 years
Medica S.p.A | Subsequent Event
Business Acquisition
Equity method investment (as a percent)	49%	49%
Payments to acquire equity method investments	$ 68	€ 62
Univercells Technologies
Business Acquisition
Acquisitions, net of cash acquired			147.2	€ 134.6
Goodwill			95.8							95.8
Intangible assets acquired			52.5							52.5
Deferred tax liabilities			13.1							13.1
Deferred tax assets			7							7
Net working capital			(0.9)							(0.9)
Other non-current assets			6.6							6.6
Other non-current liabilities			$ 0.7							$ 0.7
Isolere
Business Acquisition
Acquisitions, net of cash acquired					$ 62.4
Goodwill					28.2
Intangible assets acquired					44.5
Deferred tax liabilities					10.9
Net working capital					(0.4)
Other non-current assets					1.2
Other non-current liabilities					$ 0.2
Purilogics, LLC
Business Acquisition
Acquisitions, net of cash acquired						19.9
Maximum payout of contingent consideration						$ 29					$ 29
Solaris Biotechnology Srl
Business Acquisition
Acquisitions, net of cash acquired							$ 45.7	€ 41
Pearson Arnold Industrial Services
Business Acquisition
Acquisitions, net of cash acquired							$ 3.3

Acquisitions and Equity Metho_4

Acquisitions and Equity Method Investments (Schedule of Components of Acquisitions, Net of Cash Acquired) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Business Acquisition
Goodwill	$ 478.4	$ 481.1	$ 345.8
Acquisitions, net of cash acquired	$ 2	209.2	$ 68.9
Isolere and Univercells
Business Acquisition
Intangible assets acquired		97
Tangible assets, net		10.4
Assets acquired, net		107.4
Goodwill		124
Aggregate purchase price		231.4
Add deferred tax asset		7
Less deferred tax liability		(24)
Less cash acquired		(4.8)
Acquisitions, net of cash acquired		209.6
Isolere and Univercells | Technology
Business Acquisition
Intangible assets acquired		84.9
Isolere and Univercells | Trademarks and tradenames
Business Acquisition
Intangible assets acquired		8.2
Isolere and Univercells | Customer relationships
Business Acquisition
Intangible assets acquired		1.2
Isolere and Univercells | Non-competition agreements
Business Acquisition
Intangible assets acquired		$ 2.7

Revenue (Disaggregation of Reve

Revenue (Disaggregation of Revenue by Geographic Region) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Disaggregation of Revenue
Net sales	$ 3,586.3	$ 3,430.8	$ 3,306.6
U.S. and Canada
Disaggregation of Revenue
Net sales	1,583.1	1,464.7	1,336.8
Europe, Middle East and Africa (EMEA)
Disaggregation of Revenue
Net sales	1,012.9	1,007.8	963.6
Asia Pacific (APAC)
Disaggregation of Revenue
Net sales	601.5	608.8	669
Latin America (LATAM)
Disaggregation of Revenue
Net sales	$ 388.8	$ 349.5	$ 337.2

Revenue (Narrative) (Details)

Revenue (Narrative) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Revenue from Contract with Customer [Abstract]
Contract with customer asset	$ 15.9	$ 13.3
Contract with customer liability	$ 19.7	$ 25.3

Inventories, Net (Details)

Inventories, Net (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Inventory, Net [Abstract]
Raw materials	$ 177.4	$ 155.1
Work in process	61.2	50.9
Finished products	238.1	212.1
Total inventories, net	$ 476.7	$ 418.1

Property, Plant and Equipment_3

Property, Plant and Equipment, Net (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Property, Plant and Equipment
Less accumulated depreciation	$ (1,091.1)	$ (1,045.9)
Total property, plant and equipment, net	645.5	652.9	$ 594.4
Land
Property, Plant and Equipment
Property, plant and equipment, gross	29.5	29.3
Buildings
Property, Plant and Equipment
Property, plant and equipment, gross	451.9	430.8
Machinery and equipment
Property, Plant and Equipment
Property, plant and equipment, gross	1,052.1	989
Computer software
Property, Plant and Equipment
Property, plant and equipment, gross	134.7	142
Construction in progress
Property, Plant and Equipment
Property, plant and equipment, gross	$ 68.4	$ 107.7

Goodwill and Intangible Asset_2

Goodwill and Intangible Assets (Reconciliation of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Goodwill
Beginning balance	$ 481.1	$ 345.8
Goodwill acquired	1.9	125.1
Purchase price adjustments	(1.1)
Foreign exchange translation	(3.5)	10.2
Ending balance	478.4	481.1
Mobile Solutions Segment
Goodwill
Beginning balance	25.5	25.3
Goodwill acquired	0	0
Purchase price adjustments	0
Foreign exchange translation	(0.1)	0.2
Ending balance	25.4	25.5
Industrial Solutions Segment
Goodwill
Beginning balance	289.1	282.1
Goodwill acquired	1.9	0
Purchase price adjustments	0
Foreign exchange translation	(1.1)	7
Ending balance	289.9	289.1
Life Sciences Segment
Goodwill
Beginning balance	166.5	38.4
Goodwill acquired	0	125.1
Purchase price adjustments	(1.1)
Foreign exchange translation	(2.3)	3
Ending balance	$ 163.1	$ 166.5

Goodwill and Intangible Asset_3

Goodwill and Intangible Assets (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Finite-Lived Intangible Assets
Finite-lived intangible assets, foreign currency translation gain (loss)	$ (1.4)	$ 3.2
Intangible asset amortization expense	$ 15.7	$ 11.4	$ 9.2
Non-competition agreements
Finite-Lived Intangible Assets
Finite lived intangible asset estimated useful life (in years)	2 years 8 months 12 days	3 years 1 month 6 days
Customer relationships
Finite-Lived Intangible Assets
Finite lived intangible asset estimated useful life (in years)	9 years 4 months 24 days	10 years 9 months 18 days
Univercells Technologies
Finite-Lived Intangible Assets
Intangible assets		$ 52.5
Univercells Technologies | Technology
Finite-Lived Intangible Assets
Intangible assets		$ 43.2
Finite lived intangible asset estimated useful life (in years)		18 years
Univercells Technologies | Trademarks and tradenames
Finite-Lived Intangible Assets
Intangible assets		$ 6.7
Finite lived intangible asset estimated useful life (in years)		10 years
Univercells Technologies | Non-competition agreements
Finite-Lived Intangible Assets
Intangible assets		$ 1.4
Finite lived intangible asset estimated useful life (in years)		2 years
Univercells Technologies | Customer relationships
Finite-Lived Intangible Assets
Intangible assets		$ 1.2
Finite lived intangible asset estimated useful life (in years)		10 years
Isolere
Finite-Lived Intangible Assets
Intangible assets		$ 44.5
Isolere | Technology
Finite-Lived Intangible Assets
Intangible assets		$ 41.7
Finite lived intangible asset estimated useful life (in years)		20 years
Isolere | Trademarks and tradenames
Finite-Lived Intangible Assets
Intangible assets		$ 1.5
Finite lived intangible asset estimated useful life (in years)		10 years
Isolere | Non-competition agreements
Finite-Lived Intangible Assets
Intangible assets		$ 1.3
Finite lived intangible asset estimated useful life (in years)		3 years

Goodwill and Intangible Asset_4

Goodwill and Intangible Assets (Reconciliation of Intangible Assets) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Finite-Lived Intangible Assets
Gross Carrying Amount	$ 237.9	$ 277.4
Accumulated Amortization	(66)	(89.3)
Net	$ 171.9	$ 188.1
Customer relationships
Finite-Lived Intangible Assets
Weighted Amortizable Life (in Years)	9 years 4 months 24 days	10 years 9 months 18 days
Gross Carrying Amount	$ 77.4	$ 107.8
Accumulated Amortization	(39.9)	(65.6)
Net	$ 37.5	$ 42.2
Trademarks
Finite-Lived Intangible Assets
Weighted Amortizable Life (in Years)	8 years 1 month 6 days	9 years
Gross Carrying Amount	$ 14.2	$ 15.9
Accumulated Amortization	(3.8)	(3.9)
Net	$ 10.4	$ 12
Technology and patents
Finite-Lived Intangible Assets
Weighted Amortizable Life (in Years)	16 years 8 months 12 days	17 years 7 months 6 days
Gross Carrying Amount	$ 142.4	$ 149.7
Accumulated Amortization	(20.4)	(19.2)
Net	$ 122	$ 130.5
Non-competition agreements
Finite-Lived Intangible Assets
Weighted Amortizable Life (in Years)	2 years 8 months 12 days	3 years 1 month 6 days
Gross Carrying Amount	$ 3.9	$ 4
Accumulated Amortization	(1.9)	(0.6)
Net	$ 2	$ 3.4

Goodwill and Intangible Asset_5

Goodwill and Intangible Assets (Expected Amortization Expense Relating to Existing Intangible Assets) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity
2025	$ 15.3
2026	14.1
2027	13.7
2028	13.2
2029	12.1
Thereafter	103.5
Net	$ 171.9	$ 188.1

Short-Term Borrowings and Lon_3

Short-Term Borrowings and Long-Term Debt (Short-term Borrowings) (Details) - USD ($)	Jul. 31, 2024	Jul. 31, 2023
Short-term Debt
Short-term borrowings	$ 28,300,000	$ 34,100,000
Line of Credit
Short-term Debt
Available credit facilities	303,400,000	306,100,000
Short-term borrowings	92,900,000	81,700,000
Remaining borrowing capacity	$ 210,500,000	$ 224,400,000
Weighted average interest rate (as a percent)	3.62%	4.69%
Line of Credit | Outstanding borrowings
Short-term Debt
Short-term borrowings	$ 28,300,000	$ 34,100,000
Line of Credit | Other non-borrowing reductions
Short-term Debt
Short-term borrowings	64,600,000	47,600,000
European | European Commercial Paper Program
Short-term Debt
Available credit facilities	108,300,000	110,300,000
Short-term borrowings	22,800,000	24,300,000
Remaining borrowing capacity	$ 85,500,000	$ 86,000,000
Weighted average interest rate (as a percent)	4.34%	4.09%
European | European Commercial Paper Program | Outstanding borrowings
Short-term Debt
Short-term borrowings	$ 22,800,000	$ 24,300,000
European | European Commercial Paper Program | Other non-borrowing reductions
Short-term Debt
Short-term borrowings	0	0
European | Line of Credit
Short-term Debt
Available credit facilities	48,400,000	45,000,000
Short-term borrowings	38,900,000	28,800,000
Remaining borrowing capacity	9,500,000	16,200,000
European | Line of Credit | Outstanding borrowings
Short-term Debt
Short-term borrowings	0	0
European | Line of Credit | Other non-borrowing reductions
Short-term Debt
Short-term borrowings	38,900,000	28,800,000
U.S. Credit Facilities | Line of Credit
Short-term Debt
Available credit facilities	100,000,000	100,000,000
Short-term borrowings	200,000	9,800,000
Remaining borrowing capacity	$ 99,800,000	$ 90,200,000
Weighted average interest rate (as a percent)	6.44%	6.17%
U.S. Credit Facilities | Line of Credit | Outstanding borrowings
Short-term Debt
Short-term borrowings	$ 200,000	$ 9,800,000
U.S. Credit Facilities | Line of Credit | Other non-borrowing reductions
Short-term Debt
Short-term borrowings	0	0
Rest of the World Credit Facilities | Line of Credit
Short-term Debt
Available credit facilities	46,700,000	50,800,000
Short-term borrowings	31,000,000	18,800,000
Remaining borrowing capacity	$ 15,700,000	32,000,000
Weighted average interest rate (as a percent)	0.56%
Rest of the World Credit Facilities | Line of Credit | Outstanding borrowings
Short-term Debt
Short-term borrowings	$ 5,300,000	0
Rest of the World Credit Facilities | Line of Credit | Other non-borrowing reductions
Short-term Debt
Short-term borrowings	$ 25,700,000	$ 18,800,000

Short-Term Borrowings and Lon_4

Short-Term Borrowings and Long-Term Debt (Long-term Debt) (Details)	Jul. 31, 2024 USD ($)	Jul. 31, 2024 EUR (€)	Jul. 31, 2024 JPY (¥)	Jul. 31, 2023 USD ($)
Debt Instrument
Debt issuance costs, net	$ (1,600,000)			$ (1,800,000)
Subtotal	508,400,000			621,600,000
Less current maturities	(25,000,000)			(125,000,000)
Long-term debt	483,400,000			$ 496,600,000
Unsecured Senior Notes Due March 2024 | Unsecured Notes
Debt Instrument
Amount	$ 125,000,000
Debt instrument interest rate (as a percent)	3.72%	3.72%	3.72%	3.72%
Long-term debt, gross	$ 0			$ 125,000,000
Unsecured Senior Notes Due June 2030 | Unsecured Notes
Debt Instrument
Amount	$ 125,000,000
Debt instrument interest rate (as a percent)	3.18%	3.18%	3.18%	3.18%
Long-term debt, gross	$ 125,000,000			$ 125,000,000
Unsecured Senior Notes Due 2031 | Unsecured Notes
Debt Instrument
Amount	$ 100,000,000
Debt instrument interest rate (as a percent)	2.50%	2.50%	2.50%	2.50%
Long-term debt, gross	$ 100,000,000			$ 100,000,000
Variable Rate Committed Revolving Credit Facility Due 2026 | Unsecured Notes | Unsecured Revolving Credit Facility
Debt Instrument
Amount	$ 500,000,000
Debt instrument interest rate (as a percent)	6.44%	6.44%	6.44%	5.09%
Long-term debt, gross	$ 110,000,000			$ 96,200,000
Variable Rate Committed Unsecured Term Loan Due 2029 | Unsecured Notes
Debt Instrument
Amount | €		€ 80,000,000
Debt instrument interest rate (as a percent)	4.69%	4.69%	4.69%	4.41%
Long-term debt, gross	$ 86,600,000			$ 88,200,000
Unsecured Senior Notes Due 2028 | Unsecured Notes
Debt Instrument
Amount	$ 50,000,000
Debt instrument interest rate (as a percent)	2.12%	2.12%	2.12%	2.12%
Long-term debt, gross	$ 50,000,000			$ 50,000,000
Unsecured Senior Notes Due 2025 | Unsecured Notes
Debt Instrument
Amount	$ 25,000,000
Debt instrument interest rate (as a percent)	2.93%	2.93%	2.93%	2.93%
Long-term debt, gross	$ 25,000,000			$ 25,000,000
Variable Rate Guaranteed Senior Note Due 2028 | Unsecured Notes
Debt Instrument
Amount | ¥			¥ 1,000,000,000
Debt instrument interest rate (as a percent)	0.76%	0.76%	0.76%	0.57%
Long-term debt, gross	$ 6,700,000			$ 7,000,000
Variable Rate Guaranteed Senior Note Due 2026 | Unsecured Notes
Debt Instrument
Amount | ¥			¥ 1,000,000,000
Debt instrument interest rate (as a percent)	0.68%	0.68%	0.68%	0.49%
Long-term debt, gross	$ 6,700,000			$ 7,000,000

Short-Term Borrowings and Lon_5

Short-Term Borrowings and Long-Term Debt (Narrative) (Details) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Line of Credit
Debt Instrument
Borrowing capacity	$ 303,400,000	$ 306,100,000
Unsecured Revolving Credit Facility
Debt Instrument
Borrowing capacity	63,000,000
Long-term remaining borrowing capacity	$ 382,500,000
Unsecured Revolving Credit Facility | Minimum
Debt Instrument
Commitment fee (as a percent)	0.08%
Unsecured Revolving Credit Facility | Maximum
Debt Instrument
Commitment fee (as a percent)	0.25%
Unsecured Revolving Credit Facility | 1.29 % Variable Rate Unsecured Revolving Credit Facility Maturing 2026
Debt Instrument
Borrowing capacity	$ 500,000,000
Multi-currency revolving credit facility
Debt Instrument
Borrowing capacity	17,000,000
Multi-currency revolving credit facility | Line of Credit
Debt Instrument
Additional borrowing capacity on line of credit under certain conditions	$ 250,000,000

Short-Term Borrowings and Lon_6

Short-Term Borrowings and Long-Term Debt (Future Maturities of Long Term Debt) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Maturities of Long-term Debt
2025	$ 25
2026	116.7
2027	0
2028	6.7
2029	136.6
Thereafter	225
Total future maturities payments	510
Debt issuance costs, net	(1.6)	$ (1.8)
Subtotal	$ 508.4

Income Taxes (Components of Ear

Income Taxes (Components of Earnings Before Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Earnings before income taxes:
U.S.	$ 233.4	$ 178	$ 132.8
Foreign	301.9	290.7	305.6
Total	$ 535.3	$ 468.7	$ 438.4

Income Taxes (Components of the

Income Taxes (Components of the Provision for Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Current
Federal	$ 47.2	$ 38.1	$ 17.4
State	8.8	7.3	4.9
Foreign	89.6	79.8	84.7
Total current	145.6	125.2	107
Deferred
Federal	(16.1)	(13.3)	2.8
State	(1.7)	(1.8)	(0.3)
Foreign	(6.5)	(0.2)	(3.9)
Total deferred	(24.3)	(15.3)	(1.4)
Total provision for income taxes	$ 121.3	$ 109.9	$ 105.6

Income Taxes (Reconciliation of

Income Taxes (Reconciliation of U.S. Statutory Income Tax Rate with Effective Income Tax Rate) (Details)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Income Tax Disclosure [Abstract]
U.S. statutory federal income tax rate	21%	21%	21%
State income taxes	1.20%	0.90%	0.90%
Foreign operations	2.70%	3.80%	3.60%
Global Intangible Low Tax Income	0.20%	0.20%	0.30%
Foreign Derived Intangible Income	(1.30%)	(1.60%)	(0.60%)
Research and development credit	(0.90%)	(0.70%)	(0.60%)
Change in unrecognized tax benefits	1.20%	0%	(0.80%)
Tax benefits on stock-based compensation	(1.20%)	(0.70%)	(0.50%)
Other	(0.20%)	0.50%	0.80%
Effective income tax rate	22.70%	23.40%	24.10%

Income Taxes (Temporary Differe

Income Taxes (Temporary Differences that Give Rise to Deferred Tax Assets and Liabilities) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Deferred tax assets
Accrued expenses	$ 14.3	$ 12.2
Compensation and retirement plans	26.6	24.7
Capitalization of R&D costs	32.9	17.6
Net operating loss (NOL) and tax credit carryforwards	17.6	15.1
Operating lease assets	15.6	15
Other	6.2	6.2
Gross deferred tax assets	113.2	90.8
Valuation allowance	(9.1)	(6.4)	$ (3.4)	$ (4.6)
Deferred tax assets, net of valuation allowance	104.1	84.4
Deferred tax liabilities
Depreciation and amortization	(74.5)	(79.5)
Operating lease liabilities	(14.9)	(15.1)
Other	(3.8)	(4.2)
Deferred tax liabilities	(93.2)	(98.8)
Net deferred tax asset (liability)	$ 10.9
Net deferred tax asset (liability)		$ (14.4)

Income Taxes (NOL and Tax Credi

Income Taxes (NOL and Tax Credit Valuation Allowances) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Valuation Allowance, Deferred Tax Asset
Balance as of beginning of year	$ (6.4)	$ (3.4)	$ (4.6)
Additions charged to costs and expenses	(3.6)	(3)	(0.9)
Deductions from reserves	0.9	0	2.1
Balance as of end of year	$ (9.1)	$ (6.4)	$ (3.4)

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Income Tax Contingency
Deferred tax asset, federal foreign tax credit	$ 6.3
Deferred tax asset, research and development credit	3.4
Tax credit carryforwards	6.4
Operating losses and tax credit carryforward valuation allowance	9.1	$ 6.4	$ 3.4	$ 4.6
Undistributed earnings	1,400
Undistributed earnings not considered reinvested	1,000
Undistributed earnings tax charge	6.6
Undistributed earnings considered reinvested	380.8
Transition tax not due within 12 months	22.1
Gross accrued interest and penalties	2.2	$ 1.7
Interest expense recognized	$ 0.8
Unrecognized tax benefits, statue of limitation term (in years)	5 years
Unrecognized tax benefits	$ 3.1
Federal Tax Credits | Minimum
Income Tax Contingency
Credit carry forward term (in years)	10 years
Research And Development Credits | Minimum
Income Tax Contingency
Credit carry forward term (in years)	1 year
Research And Development Credits | Maximum
Income Tax Contingency
Credit carry forward term (in years)	20 years

Income Taxes (Reconciliation _2

Income Taxes (Reconciliation of Beginning and Ending Amount of Gross Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Reconciliation of the Beginning and Ending Amounts of Gross Unrecognized Tax Benefits
Balance as of beginning of year	$ 15	$ 15.2	$ 18.7
Additions for tax positions of the current year	2.8	2.5	2.7
Additions for tax positions of prior years	6.2	0.1	0
Reductions for tax positions of prior years	(0.1)		(1.1)
Reductions due to lapse of applicable statute of limitations	(3.1)	(2.8)	(5.1)
Balance as of end of year	$ 20.8	$ 15	$ 15.2

Leases (Lease Cost) (Details)

Leases (Lease Cost) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Leases [Abstract]
Operating lease cost	$ 29.5	$ 24.5
Short-term lease cost	3	3.2
Total lease costs	$ 32.5	$ 27.7

Leases (Supplemental Informatio

Leases (Supplemental Information) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Leases [Abstract]
Right-of-use lease assets	$ 59.7	$ 59.4
Current lease liabilities	20.2	17.8
Long-term lease liabilities	$ 41.3	$ 42.4
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other long-term assets	Other long-term assets
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Other current liabilities	Other current liabilities
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities	Other long-term liabilities
Weighted average remaining lease term (years)	3 years 6 months	4 years 2 months 12 days
Weighted average discount rates (as a percentage)	4.61%	3.89%

Leases (Maturities) (Details)

Leases (Maturities) (Details) $ in Millions	Jul. 31, 2024 USD ($)
Lessee, Operating Lease, Liability, Payment, Due
2025	$ 23
2026	18.5
2027	12.2
2028	6.9
2029	4.6
Thereafter	2.4
Total future lease payments	67.6
Less imputed interest	6.1
Present value of future lease payments	$ 61.5

Earnings Per Share (Information

Earnings Per Share (Information Necessary to Calculate Basic and Diluted Net Earnings Per Common Share) (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Earnings Per Share [Abstract]
Net earnings	$ 414	$ 358.8	$ 332.8
Weighted average common shares outstanding
Weighted average common shares – basic (in shares)	120.7	121.8	123.7
Dilutive impact of share-based awards (in shares)	1.9	1.8	1.5
Weighted average common shares – diluted (in shares)	122.6	123.6	125.2
Net EPS – basic (in usd per share)	$ 3.43	$ 2.95	$ 2.69
Net EPS– diluted (in usd per share)	$ 3.38	$ 2.90	$ 2.66
Stock options excluded from net EPS calculation (in shares)	0	0	1.6

Stockholders' Equity (Narrative

Stockholders' Equity (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	3 Months Ended	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Nov. 30, 2023
Stockholders' Equity Note [Abstract]
Stock repurchase program, additional shares authorized for repurchase (in shares)					12,000,000
Stock repurchases (in shares)		2,500,000	2,500,000
Stock repurchased during the period including excise tax		$ 163.3
Purchase of treasury stock		$ 162.7	$ 141.8	$ 170.6
Remaining number of shares authorized to be repurchased (in shares)	10,700,000	10,700,000
Dividends paid per share (in usd per share)		$ 1.02	$ 0.940
Cash dividend declared per common share (in usd per share)	$ 0.270	$ 1.04	$ 0.96	$ 0.90

Stockholders' Equity (Treasury

Stockholders' Equity (Treasury Stock) (Details) - shares	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Schedule of Treasury Shares Activity
Balance as of beginning of year (in shares)	30,528,696
Stock repurchases (in shares)	2,500,000	2,500,000
Net issuance upon exercise of stock options (in shares)	(1,372,191)
Balance as of end of year (in shares)	31,533,192	30,528,696
Treasury Stock
Schedule of Treasury Shares Activity
Balance as of beginning of year (in shares)	30,528,696	29,089,612
Stock repurchases (in shares)	2,465,000	2,485,000
Net issuance upon exercise of stock options (in shares)	(1,294,475)	(941,837)
Issuance under compensation plans (in shares)	(149,329)	(84,942)
Other activity (in shares)	(16,700)	(19,137)
Balance as of end of year (in shares)	31,533,192	30,528,696

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	$ 1,320.7	$ 1,133.2	$ 1,137.1
Other comprehensive loss before reclassifications and tax	(34)	25.2
Tax benefit	2.5	2.7
Other comprehensive loss before reclassifications, net of tax	(31.5)	27.9
Reclassifications, before tax	6.6	7.8
Tax expense	(1.5)	(2.6)
Reclassifications, net of tax	5.1	5.2
Net other comprehensive (loss) income	(26.4)	33.1	(87.4)
Ending balance	1,489.1	1,320.7	1,133.2
Total
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	(172.5)	(205.6)	(118.2)
Ending balance	(198.9)	(172.5)	(205.6)
Foreign Currency Translation Adjustment
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	(109.6)	(143.6)
Other comprehensive loss before reclassifications and tax	(24.2)	34
Tax benefit	0	0
Other comprehensive loss before reclassifications, net of tax	(24.2)	34
Reclassifications, before tax	0	0
Tax expense	0	0
Reclassifications, net of tax	0	0
Net other comprehensive (loss) income	(24.2)	34
Ending balance	(133.8)	(109.6)	(143.6)
Pension Benefits
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	(67.2)	(67.5)
Other comprehensive loss before reclassifications and tax	(9)	(6.9)
Tax benefit	2.3	2.2
Other comprehensive loss before reclassifications, net of tax	(6.7)	(4.7)
Reclassifications, before tax	6.3	7.5
Tax expense	(1.5)	(2.5)
Reclassifications, net of tax	4.8	5
Net other comprehensive (loss) income	(1.9)	0.3
Ending balance	(69.1)	(67.2)	(67.5)
Pension Benefits | Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax
Reclassifications, before tax	4.8	6.6
Derivative Financial Instruments
Accumulated Other Comprehensive Income (Loss), Net of Tax
Beginning balance	4.3	5.5
Other comprehensive loss before reclassifications and tax	(0.8)	(1.9)
Tax benefit	0.2	0.5
Other comprehensive loss before reclassifications, net of tax	(0.6)	(1.4)
Reclassifications, before tax	0.3	0.3
Tax expense	0	(0.1)
Reclassifications, net of tax	0.3	0.2
Net other comprehensive (loss) income	(0.3)	(1.2)
Ending balance	4	4.3	$ 5.5
Accumulated Defined Benefit Plans Adjustment, Foreign Currency Translation Attributable To Parent | Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax
Reclassifications, before tax	0.1	(1.4)
Net Amortization of Prior Service Cost and Actuarial Losses | Adjustments
Accumulated Other Comprehensive Income (Loss), Net of Tax
Other comprehensive loss before reclassifications and tax	$ (1.4)	$ (2.3)

Stock-Based Compensation (Narra

Stock-Based Compensation (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Stock options, weighted average grant date fair value (in usd per share)	$ 19	$ 15.67	$ 14.24
Intrinsic value of stock options exercised	$ 35.9	$ 20.2	$ 7.8
Intrinsic value of shares outstanding	149.5
Intrinsic value of shares exercisable	119.6
Stock Options
Share-based Compensation Arrangement by Share-based Payment Award
Pre-tax compensation expense associated with stock options	$ 14.2	12.4	11.6
Shares reserved for outstanding options and future grants (in shares)	11,954,309
Total unrecognized compensation expense related to non-vested stock options	$ 8.6
Stock Options | 2019 Master Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Stock options exercisable term (in years)	10 years
Stock option, award vesting period (in years)	3 years
Performance Shares
Share-based Compensation Arrangement by Share-based Payment Award
Total unrecognized compensation expense related to non-vested stock options	$ 6.2
Performance Shares | 2019 Master Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award
Pre-tax compensation expense associated with stock options	$ 5.8	$ 6.3	$ 7.2
Performance awards measurement period (in years)	3 years
Expiration period (in years)	3 years
Performance Shares | 2019 Master Stock Incentive Plan | Minimum
Share-based Compensation Arrangement by Share-based Payment Award
Payout percentage based on target award (as a percent)	0%
Performance Shares | 2019 Master Stock Incentive Plan | Maximum
Share-based Compensation Arrangement by Share-based Payment Award
Payout percentage based on target award (as a percent)	200%

Stock-Based Compensation (Weigh

Stock-Based Compensation (Weighted Average Assumptions for Recognized Fair Value of Stock-Based Employee Compensation Cost) (Details)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Share-based Compensation Arrangement by Share-based Payment Award
Risk-free interest rate, min (as a percent)	3.80%	3.80%	1.20%
Risk-free interest rate, max (as a percent)	4.60%	4.20%	1.80%
Expected volatility, min (as a percent)	26.80%	26.80%	26%
Expected volatility, max (as a percent)	27.20%	27.50%	27%
Expected dividend yield (as a percent)	1.60%	1.60%	1.60%
Director grants
Share-based Compensation Arrangement by Share-based Payment Award
Expected life (in years)	8 years	8 years	8 years
Officer grants
Share-based Compensation Arrangement by Share-based Payment Award
Expected life (in years)	7 years	7 years	7 years
Non-officer grants
Share-based Compensation Arrangement by Share-based Payment Award
Expected life (in years)	7 years	7 years	7 years

Stock-Based Compensation (Stock

Stock-Based Compensation (Stock Option Activity) (Details)	12 Months Ended
	Jul. 31, 2024 $ / shares shares
Options
Beginning balance (in shares) | shares	6,777,407
Granted (in shares) | shares	809,278
Exercised (in shares) | shares	(1,372,191)
Expired/forfeited (in shares) | shares	(51,438)
Ending balance (in shares) | shares	6,163,056
Weighted Average Exercise Price
Beginning balance (in usd per share) | $ / shares	$ 47.80
Granted (in usd per share) | $ / shares	59.95
Exercised (in usd per share) | $ / shares	42.30
Expired/forfeited (in usd per share) | $ / shares	54.14
Ending balance (in usd per share) | $ / shares	$ 50.57

Stock-Based Compensation (Infor

Stock-Based Compensation (Information Concerning Outstanding and Exercisable Options) (Details) - $ / shares	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Number outstanding (in shares)	6,163,056	6,777,407
Weighted average remaining contractual life (in years)	5 years 7 months 6 days
Weighted average exercise price (in usd per share)	$ 50.57
Number exercisable (in shares)	4,505,086
Weighted average remaining contractual life (in years)	4 years 6 months
Weighted average exercise price (in usd per share)	$ 48.27
$28.00 to $37.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Stock options, exercise price range, lower range limit (in usd per share)	28
Share options, exercise price range, upper range limit (in usd per share)	$ 37.99
Number outstanding (in shares)	494,960
Weighted average remaining contractual life (in years)	1 year 3 months 18 days
Weighted average exercise price (in usd per share)	$ 29.54
Number exercisable (in shares)	494,960
Weighted average remaining contractual life (in years)	1 year 3 months 18 days
Weighted average exercise price (in usd per share)	$ 29.54
$38.00 to $43.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Stock options, exercise price range, lower range limit (in usd per share)	38
Share options, exercise price range, upper range limit (in usd per share)	$ 43.99
Number outstanding (in shares)	620,682
Weighted average remaining contractual life (in years)	2 years 3 months 18 days
Weighted average exercise price (in usd per share)	$ 42.25
Number exercisable (in shares)	620,682
Weighted average remaining contractual life (in years)	2 years 3 months 18 days
Weighted average exercise price (in usd per share)	$ 42.25
$44.00 to $49.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Stock options, exercise price range, lower range limit (in usd per share)	44
Share options, exercise price range, upper range limit (in usd per share)	$ 49.99
Number outstanding (in shares)	1,255,623
Weighted average remaining contractual life (in years)	4 years 10 months 24 days
Weighted average exercise price (in usd per share)	$ 45.97
Number exercisable (in shares)	1,255,623
Weighted average remaining contractual life (in years)	4 years 10 months 24 days
Weighted average exercise price (in usd per share)	$ 45.97
$50.00 to $55.99
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Stock options, exercise price range, lower range limit (in usd per share)	50
Share options, exercise price range, upper range limit (in usd per share)	$ 55.99
Number outstanding (in shares)	1,538,333
Weighted average remaining contractual life (in years)	6 years 9 months 18 days
Weighted average exercise price (in usd per share)	$ 51.33
Number exercisable (in shares)	977,432
Weighted average remaining contractual life (in years)	6 years
Weighted average exercise price (in usd per share)	$ 51.58
$56.00 and above
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range
Stock options, exercise price range, lower range limit (in usd per share)	$ 56
Number outstanding (in shares)	2,253,458
Weighted average remaining contractual life (in years)	7 years
Weighted average exercise price (in usd per share)	$ 59.52
Number exercisable (in shares)	1,156,389
Weighted average remaining contractual life (in years)	5 years 6 months
Weighted average exercise price (in usd per share)	$ 59.23

Stock-Based Compensation (Statu

Stock-Based Compensation (Status for Options Which Contain Vesting Provisions) (Details) - $ / shares	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Options
Balance outstanding as of beginning of year (in shares)	1,783,711
Granted (in shares)	809,278
Vested (in shares)	(893,885)
Forfeited (in shares)	(41,134)
Balance outstanding as of ending of year (in shares)	1,657,970	1,783,711
Weighted Average Grant Date Fair Value
Balance outstanding as of beginning of year (in usd per share)	$ 14.27
Granted (in usd per share)	19	$ 15.67	$ 14.24
Vested (in usd per share)	13.34
Forfeited (in usd per share)	16.61
Balance outstanding as of beginning of year (in usd per share)	$ 17.02	$ 14.27

Stock-Based Compensation (Sta_2

Stock-Based Compensation (Status for Performance-Based Awards Which Contain Vesting Provisions) (Details) - Performance Shares - $ / shares	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Performance Shares
Beginning balance (in shares)	194,761
Granted (in shares)	114,800
Vested (in shares)	(81,661)
Forfeited (in shares)	0
Ending balance (in shares)	227,900	194,761
Weighted Average Grant Date Fair Value
Beginning balance (in usd per share)	$ 54.46
Granted (in usd per share)	59.66	$ 50.89	$ 59.40
Vested (in usd per share)	59.40
Forfeited (in usd per share)	0
Ending balance (in usd per share)	$ 55.31	$ 54.46

Employee Benefit Plans (Compone

Employee Benefit Plans (Components of Net Periodic Pension Costs) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Net periodic pension costs
Service cost	$ 5.2	$ 6.7	$ 6.9
Interest cost	20.4	17	10.6
Expected return on assets	(25.7)	(25.3)	(24.8)
Prior service cost amortization	0.1	0	0.2
Actuarial loss amortization	1.5	2.1	6.9
Settlement loss	4.9	5.5	3
Curtailment loss	0.2	0.2	0
Net periodic pension costs	$ 6.6	$ 6.2	$ 2.8
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Excluding Service Cost, Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Curtailment Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)	Other Nonoperating Income (Expense)
Other changes recognized in other comprehensive (loss) income:
Prior service cost	$ 0.1	$ (0.4)	$ 0
Net actuarial (loss) gain	(9.1)	(5.9)	(1.3)
Amortization of prior service cost	0.3	0.2	0.3
Amortization of net actuarial loss	6.4	7.7	9.9
Total recognized in other comprehensive (loss) income	(2.3)	1.6	8.9
Total recognized in net periodic pension costs and other comprehensive (loss) income	$ (8.9)	$ (4.6)	$ 6.1

Employee Benefit Plans (Obligat

Employee Benefit Plans (Obligations and Funded Status of Company's Pension Plans) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Change in projected benefit obligation
Service cost	$ 5.2	$ 6.7	$ 6.9
Interest cost	20.4	17	10.6
Actuarial (gain) loss	1.5	2.1	6.9
Pension Plan
Change in projected benefit obligation
Projected benefit obligation, beginning of year	401.1	442.6
Service cost	5.2	6.7
Interest cost	20.4	17
Plan amendments	(0.1)	0.2
Participant contributions	0.8	0.7
Actuarial (gain) loss	11.7	(42)
Foreign currency exchange rates	(1.8)	9.2
Settlements paid	(15.6)	(17)
Acquisition	0.6	1.2
Benefits paid	(18.6)	(17.5)
Projected benefit obligation, end of year	403.7	401.1	442.6
Change in fair value of plan assets
Fair value of plan assets, beginning of year	416	459.8
Actual return on plan assets	28.4	(22.1)
Company contributions	2.8	2.6
Participant contributions	0.8	0.7
Foreign currency exchange rates	(1.1)	8.3
Settlements paid	(15.6)	(17)
Acquisition	0.6	1.2
Benefits paid	(18.6)	(17.5)
Fair value of plan assets, end of year	413.3	416	$ 459.8
Defined Benefit Plan, Funded (Unfunded) Status of Plan
Funded status of plans, end of year	9.6	14.9
Amounts recognized on the Consolidated Balance Sheets
Other long-term assets	35.8	34.7
Other current liabilities	(1.5)	(1.7)
Other long-term liabilities	(24.7)	(18.1)
Net recognized asset	$ 9.6	$ 14.9

Employee Benefit Plans (Narrati

Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Defined Benefit Plan Disclosure
Deferred compensation arrangement with individual, maximum future deferred receipts allowed (as a percent)	75%
Deferred compensation arrangement with individual, recorded liability	$ 1.2	$ 1.9
Pension Plan
Defined Benefit Plan Disclosure
Net underfunded status	(9.6)	(14.9)
Unrealized losses recognized	111.3	109
Accumulated benefit obligation	385.1	384.4
Projected benefit obligation for pension plans with projected benefit obligations in excess of plan assets	75.3	73.5
Fair value of plan assets for pension plans with projected benefit obligations in excess of plan assets	49.1	53.7
Projected benefit obligation for pension plans with accumulated benefit obligations in excess of plan assets	17.7	15
Accumulated benefit obligation for plans with projected benefit obligations in excess of plan assets	16.4	15
Fair value of plan assets for plans with projected benefit obligations in excess of plan assets	7.3	5
Cash and credit contributions	2.8
Company contributions	$ 2.8	2.6
Pension Plan | Minimum | Fixed income securities | Level 3 | Independent Insurance Company
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	80%
Pension Plan | Minimum | Global equity securities | Level 3 | Independent Insurance Company
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	10%
Pension Plan | Maximum | Fixed income securities | Level 3 | Independent Insurance Company
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	90%
Pension Plan | Maximum | Global equity securities | Level 3 | Independent Insurance Company
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	20%
Retirement Savings and Employee Stock Ownership Plan | U.S. Plan
Defined Benefit Plan Disclosure
Contributory employee saving plan, employee contribution threshold limit from compensation, maximum (as a percent)	50%
Contributory employee saving plan, percentage match of participants, first contributions (as a percent)	100%
Contributory employee saving plan, percentage of participants, first eligible compensation (as a percent)	3%
Contributory employee saving plan, percentage match of participants, second contributions (as a percent)	50%
Contributory employee saving plan, percentage of participants, second eligible compensation (as a percent)	2%
Defined contribution plan, annual retirement contributions (as a percent)	3%
Company contributions	$ 32.7	$ 28.6	$ 27.2

Employee Benefit Plans (Weighte

Employee Benefit Plans (Weighted-Average Discount Rates in Determining Actuarial Present Value of Projected Benefit Obligation) (Details) - Pension Plan	Jul. 31, 2024	Jul. 31, 2023
U.S. Plan
Defined Benefit Plan Disclosure
Discount rate (as a percent)	5.44%	5.58%
Non - U.S. Plan
Defined Benefit Plan Disclosure
Discount rate (as a percent)	4.33%	4.80%
Rate of compensation increase (as a percent)	3.05%	3.12%

Employee Benefit Plans (Assumpt

Employee Benefit Plans (Assumptions Used to Determine Net Periodic Benefit Cost) (Details) - Pension Plan	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
U.S. Plan
Defined Benefit Plan Disclosure
Discount rate (as a percent)	5.58%	4.62%	2.55%
Expected rate of return on plan assets (as a percent)	6.16%	5.66%	5.41%
Non - U.S. Plan
Defined Benefit Plan Disclosure
Discount rate (as a percent)	4.80%	3.26%	1.60%
Expected rate of return on plan assets (as a percent)	5.01%	4.39%	3.40%
Rate of compensation increase (as a percent)	3.05%	3.12%	2.99%

Employee Benefit Plans (Fair Va

Employee Benefit Plans (Fair Value of Assets Held) (Details) - Pension Plan - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022	Jul. 31, 2021
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	$ 413.3	$ 416	$ 459.8
U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	366.7	369.8
Total investment, at fair value	410.9	416
Accrued income	2.4
Total assets	413.3
Level 1 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	141	154.9
Level 2 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	183	173.6
Level 3
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	42.7	41.3	$ 35.4	$ 37.7
Level 3 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	42.7	41.3
Investments using NAV as practical expedient | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy		46.2
Investments using NAV as practical expedient	44.2	46.2
Cash and cash equivalents | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	2.9	4.3
Cash and cash equivalents | Level 1 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	2.4	3.6
Cash and cash equivalents | Level 2 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0.5	0.7
Cash and cash equivalents | Level 3 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0	0
Global equity securities | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	112.7	116.9
Global equity securities | Level 1 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	58.2	61.2
Global equity securities | Level 2 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	54.5	55.7
Global equity securities | Level 3 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0	0
Global equity securities | Investments using NAV as practical expedient | U.S. Plan
Defined Benefit Plan Disclosure
Investments using NAV as practical expedient	31.1	33.6
Fixed income securities | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	208.4	207.3
Fixed income securities | Level 1 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	80.4	90.1
Fixed income securities | Level 2 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	128	117.2
Fixed income securities | Level 3 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0	0
Fixed income securities | Investments using NAV as practical expedient | U.S. Plan
Defined Benefit Plan Disclosure
Investments using NAV as practical expedient	10.2	9.5
Insurance contracts | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	42.7	41.3
Insurance contracts | Level 1 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0	0
Insurance contracts | Level 2 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	0	0
Insurance contracts | Level 3 | U.S. Plan
Defined Benefit Plan Disclosure
Total investments in the fair value hierarchy	$ 42.7	$ 41.3

Employee Benefit Plans (Unfunde

Employee Benefit Plans (Unfunded Commitments and Redemption Restrictions) (Details) - U.S. Plan - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Unfunded Commitments	$ 6	$ 6
NAV
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
NAV	44.2	46.2
Global equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Unfunded Commitments	$ 1.8	1.8
Global equity securities | Minimum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Redemption Notice (Days)	0 days
Global equity securities | Maximum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Redemption Notice (Days)	5 days
Global equity securities | NAV
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
NAV	$ 31.1	33.6
Fixed income securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Unfunded Commitments	$ 0	0
Fixed income securities | Minimum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Redemption Notice (Days)	0 days
Fixed income securities | Maximum
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Redemption Notice (Days)	60 days
Fixed income securities | NAV
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
NAV	$ 10.2	9.5
Real asset funds
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
Unfunded Commitments	4.2	4.2
Real asset funds | NAV
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share
NAV	$ 2.9	$ 3.1

Employee Benefit Plans (Changes

Employee Benefit Plans (Changes in Fair Value of U.S. Pension Plans' Level 3 Assets) (Details) - Pension Plan - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Change in fair value of plan assets
Fair value of plan assets, beginning of year	$ 416	$ 459.8
Fair value of plan assets, end of year	413.3	416	$ 459.8
Level 3
Change in fair value of plan assets
Fair value of plan assets, beginning of year	41.3	35.4	37.7
Unrealized gains	3.4	2.7	3.5
Foreign currency exchange	(0.8)	3	(5.6)
Purchases and sales, net	(1.2)	0.2	(0.2)
Fair value of plan assets, end of year	$ 42.7	$ 41.3	$ 35.4

Employee Benefit Plans (Pension

Employee Benefit Plans (Pension Plan Target Allocation) (Details) - Pension Plan	Jul. 31, 2024
Salaried Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	100%
Hourly Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	100%
Global equity securities | Salaried Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	33%
Global equity securities | Hourly Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	32%
Fixed income securities | Salaried Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	65%
Fixed income securities | Hourly Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	67%
Real asset funds | Salaried Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	1%
Real asset funds | Hourly Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	0%
Cash and cash equivalents | Salaried Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	1%
Cash and cash equivalents | Hourly Pension Plan
Defined Benefit Plan Disclosure
Pension plan target allocation (as a percent)	1%

Employee Benefit Plans (Estimat

Employee Benefit Plans (Estimated Future Benefit Payments for U.S. and Non U.S. Plans) (Details) $ in Millions	Jul. 31, 2024 USD ($)
Defined Benefit Plan, Expected Future Benefit Payment
2025	$ 27.8
2026	27.6
2027	28.6
2028	28
2029	31.7
2030-2034	$ 158.7

Derivative Instruments and He_2

Derivative Instruments and Hedging (Details) € in Millions, $ in Millions	12 Months Ended
	Jul. 31, 2024 USD ($) derivative	Jul. 31, 2024 EUR (€) derivative	Jul. 31, 2023 USD ($) derivative
Designated as hedging instruments | Cash Flow Hedging
Derivative
Number of contracts (derivative) | derivative	0	0	0
Level 2 | Designated as hedging instruments | Net investment hedges
Derivative
Notional amount	$ 88.8	€ 80
Foreign Currency Forward Contracts
Derivative
Derivative instrument term (in months)	12 months
Foreign Currency Forward Contracts | Level 2 | Designated as hedging instruments
Derivative
Notional amount	$ 32.3		$ 84.9
Foreign Currency Forward Contracts | Level 2 | Not designated as hedging instruments
Derivative
Notional amount	$ 249.7		$ 147.5

Fair Value Measurements (Narrat

Fair Value Measurements (Narrative) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Level 3
Debt Instrument
Equity method investments	$ 26.9	$ 24.4
Fixed Interest Rate | Level 2 | Fair Value
Debt Instrument
Debt instrument, fair value disclosure	267.7	378.9
Fixed Interest Rate | Level 2 | Carrying Value
Debt Instrument
Debt instrument, fair value disclosure	300	425
Variable Interest Rate | Level 2 | Fair Value
Debt Instrument
Debt instrument, fair value disclosure	209.9	198.4
Variable Interest Rate | Level 2 | Carrying Value
Debt Instrument
Debt instrument, fair value disclosure	$ 209.9	$ 198.4

Fair Value Measurements (Fair V

Fair Value Measurements (Fair Value of Outstanding Derivatives in Consolidated Balance Sheets) (Details) - Fair Value, Inputs, Level 2 - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	$ 4.8	$ 4.9
Liabilities	0.3	1.5
Designated as hedging instruments
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	3.8	4.2
Liabilities	0	0.1
Designated as hedging instruments | Net investment hedges
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	3.7	3.6
Liabilities	0	0
Not designated as hedging instruments
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	1	0.7
Liabilities	0.3	1.4
Foreign currency forward contracts | Designated as hedging instruments
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	0.1	0.6
Liabilities	0	0.1
Foreign currency forward contracts | Not designated as hedging instruments
Fair Value, Balance Sheet Grouping, Financial Statement Captions
Assets	1	0.7
Liabilities	$ 0.3	$ 1.4

Fair Value Measurements (Compan

Fair Value Measurements (Company’s Contingent Consideration Obligations) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation
Balance at the beginning	$ 25	$ 24.7
Issuances	1	0
Settlements	$ (2)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration]	Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Adjustments to fair value	$ (2.2)	0.3
Balance at the end	21.8	25
Maximum potential payout	$ 29.7	$ 30.7

Guarantees (Balance Sheet) (Det

Guarantees (Balance Sheet) (Details) - USD ($) $ in Millions	Jul. 31, 2024	Jul. 31, 2023
Product Warranties Disclosures [Abstract]
Contingent liability for standby letters of credit issued under the Company’s revolving credit facility	$ 7.5	$ 7.5
Amounts drawn for letters of credit under the Company’s revolving credit facility	$ 0	$ 0

Guarantees (Narrative) (Details

Guarantees (Narrative) (Details) - USD ($)	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Guarantor Obligations
Investment earnings	$ 7,400,000	$ 3,600,000	$ 1,700,000
Advanced Filtration Systems Inc.
Guarantor Obligations
Investment earnings	12,300,000	8,500,000
Unsecured Revolving Credit Facility
Guarantor Obligations
Available credit facilities	63,000,000
Multi-currency revolving credit facility
Guarantor Obligations
Available credit facilities	17,000,000
Advanced Filtration Systems Inc.
Guarantor Obligations
AFSI outstanding debt (the Company guarantees half)	$ 51,000,000	$ 59,600,000

Commitments and Contingencies (

Commitments and Contingencies (Details) $ in Millions	12 Months Ended
	Jul. 31, 2024 USD ($) customer	Jul. 31, 2023 USD ($)
Business Acquisition
Accrued warranty reserves	$ 10.2	$ 5.5
Revenue Benchmark | Customer Concentration Risk
Business Acquisition
Number of customer | customer	1
Customer One | Revenue Benchmark | Customer Concentration Risk
Business Acquisition
Accrued warranty reserves	$ 4.1
Purilogics | Contingent compensation
Business Acquisition
Contingent consideration accrued	2.1
Contingent consideration, non current		1.1
Maximum payout of contingent consideration	3
Purilogics | Future Performance
Business Acquisition
Contingent consideration, liability, current	19
Contingent consideration, non current		23.2
Maximum payout of contingent consideration	27	29
Payment for contingent consideration liability, investing activities	2
Other Acquisitions
Business Acquisition
Contingent consideration accrued	0.3	0.9
Contingent consideration, liability, current	2.8
Contingent consideration, non current		1.7
Maximum payout of contingent consideration	2.8	$ 1.7
Other Acquisitions | Future Performance
Business Acquisition
Maximum payout of contingent consideration	$ 0.8
Minimum | Purilogics
Business Acquisition
Contingent consideration, terminating (in years)	2 years
Minimum | Other Acquisitions
Business Acquisition
Business combination, contingent consideration arrangements, term (in years)	2 years
Maximum | Purilogics
Business Acquisition
Contingent consideration, terminating (in years)	5 years
Maximum | Other Acquisitions
Business Acquisition
Business combination, contingent consideration arrangements, term (in years)	4 years

Segment Reporting (Narrative) (

Segment Reporting (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Segment Reporting, Measurement Disclosures [Abstract]
Restructuring charges	$ 6.4	$ 21.8

Segment Reporting (Summary of S

Segment Reporting (Summary of Segment Details) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Segment Reporting Information
Net sales	$ 3,586.3	$ 3,430.8	$ 3,306.6
Equity earnings in unconsolidated affiliates	7.4	3.6	1.7
Earnings (loss) before income taxes	535.3	468.7	438.4
Assets	2,914.3	2,770.5	2,600.3
Equity investments in unconsolidated affiliates	26.9	24.4	22.4
Operating Segments | Mobile Solutions Segment
Segment Reporting Information
Net sales	2,250.8	2,174.8	2,126.5
Equity earnings in unconsolidated affiliates	7.3	3.6	1.7
Earnings (loss) before income taxes	404.5	330.4	293.8
Assets	1,339.5	1,243.8	1,319.4
Equity investments in unconsolidated affiliates	26.8	24.2	22.3
Operating Segments | Industrial Solutions Segment
Segment Reporting Information
Net sales	1,066.5	1,014.7	901
Equity earnings in unconsolidated affiliates	0.1	0	0
Earnings (loss) before income taxes	198.8	186.2	133
Assets	821.7	788.1	816
Equity investments in unconsolidated affiliates	0.1	0.2	0.1
Operating Segments | Life Sciences Segment
Segment Reporting Information
Net sales	269	241.3	279.1
Equity earnings in unconsolidated affiliates	0	0	0
Earnings (loss) before income taxes	(10.4)	9.9	64.9
Assets	512.1	513.8	267.8
Equity investments in unconsolidated affiliates	0	0	0
Corporate and Unallocated
Segment Reporting Information
Net sales	0	0	0
Equity earnings in unconsolidated affiliates	0	0	0
Earnings (loss) before income taxes	(57.6)	(57.8)	(53.3)
Assets	241	224.8	197.1
Equity investments in unconsolidated affiliates	$ 0	$ 0	$ 0

Segment Reporting (Net Sales by

Segment Reporting (Net Sales by Product Within Engine Products Segment and Industrial Products Segment) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Segment Reporting Information
Net sales	$ 3,586.3	$ 3,430.8	$ 3,306.6
Mobile Solutions Segment | Operating Segments
Segment Reporting Information
Net sales	2,250.8	2,174.8	2,126.5
Mobile Solutions Segment | Off-Road | Operating Segments
Segment Reporting Information
Net sales	380.8	428.7	390.5
Mobile Solutions Segment | On-Road | Operating Segments
Segment Reporting Information
Net sales	139.8	145.8	136.1
Mobile Solutions Segment | Aftermarket | Operating Segments
Segment Reporting Information
Net sales	1,730.2	1,600.3	1,599.9
Industrial Solutions Segment | Operating Segments
Segment Reporting Information
Net sales	1,066.5	1,014.7	901
Industrial Solutions Segment | Industrial Filtration Solutions | Operating Segments
Segment Reporting Information
Net sales	901.1	872.2	780.5
Industrial Solutions Segment | Aerospace and Defense | Operating Segments
Segment Reporting Information
Net sales	165.4	142.5	120.5
Life Sciences Segment | Operating Segments
Segment Reporting Information
Net sales	$ 269	$ 241.3	$ 279.1

Segment Reporting (Geographic S

Segment Reporting (Geographic Sales by Origination and Property, Plant and Equipment) (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023	Jul. 31, 2022
Segment Reporting Information
Net sales	$ 3,586.3	$ 3,430.8	$ 3,306.6
Property, plant and equipment, net	645.5	652.9	594.4
U.S. and Canada
Segment Reporting Information
Net sales	1,583.1	1,464.7	1,336.8
Property, plant and equipment, net	209.7	219.7	218.1
EMEA
Segment Reporting Information
Net sales	1,012.9	1,007.8	963.6
Property, plant and equipment, net	199.6	202.4	184.3
APAC
Segment Reporting Information
Net sales	601.5	608.8	669
Property, plant and equipment, net	75.5	76.5	59.5
LATAM
Segment Reporting Information
Net sales	388.8	349.5	337.2
Property, plant and equipment, net	$ 160.7	$ 154.3	$ 132.5

Restructuring (Details)

Restructuring (Details) - USD ($) $ in Millions	12 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Restructuring Cost and Reserve
Severance costs	$ 6.4	$ 15.3
Restructuring charges	6.4	21.8
Lower Margin Customer Programs
Restructuring Cost and Reserve
Business exit cost		6.5
Cost of Sales
Restructuring Cost and Reserve
Severance costs	3.8
Restructuring charges		$ 2.9
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		Cost of sales
Operating Expense
Restructuring Cost and Reserve
Severance costs	$ 2.6
Selling, General and Administrative Expenses
Restructuring Cost and Reserve
Restructuring charges		$ 18.9
Restructuring Charges, Statement of Income or Comprehensive Income [Extensible Enumeration]		Selling, general and administrative